Professor Andrew Coats

Honorary Professor
Medicine, Sydney Medical School

Telephone +61 2 9036 9504
Fax +61 2 9036 9522

Map

Research interests

Professor Coats is a former Dean of the Faculty of Medicine at the University of Sydney and his major area of research is cardiology. He has publications in excess of 800 in various medical journals.

His main research interests are clinical integrated pathophysiological and treatment studies of heart failure; the clinical pathophysiology of familial and non-familial cardiomyopathies; the epidemiology of hypertension; ambulatory blood pressure monitoring; the development, assessment and management of hypertensive heart disease; integrated human cardiovascular physiology, and research policy and governance.

Selected grants

2006

  • CDAMS Medical Schools Outcomes Database & Longitudinal tracking; Coats A, Robinson B; Commonwealth Department of Health and Ageing/Research Grant.

2005

  • Clinical Trial Research Facilitation Agreement - Pre-Study research Meetings for Study Investigators in Australia; Picker J, Coats A; Servier Laboratories Australia/Research Support.
  • Medical Research Foundation support for the research programs of Prof Jurgen Gotz; Coats A; University of Sydney/Internal Research Grant Allocations - Medicine.

2003

  • Collaborative Cachexia Research - Visiting Professor Stefan Anker; Coats A; Par Pharmaceutical Companies Inc (USA)/Research Grant.
  • Basic Cachexia Research - Visiting Professor Stefan Anker; Coats A; Par Pharmaceutical Companies Inc (USA)/Research Grant.

2000

  • Psychological interventions to improve survival and quality of life in melanoma patients; Dunn S, Coats A, Butow P; National Health and Medical Research Council (NHMRC)/Project Grants.

Selected publications

Download citations: PDF RTF Endnote

Journals

  • Manzano, L., Babalis, D., Roughton, M., Shibata, M., Anker, S., Ghio, S., van Veldhuisen, D., Cohen-Solal, A., Coats, A., Poole-Wilson, P., et al (2011). Predictors of clinical outcomes in elderly patients with heart failure. European Journal of Heart Failure, 13(5), 528-536. [More Information]
  • Coats, A., Shewan, L. (2011). Statement on authorship and publishing ethics in the international journal of cardiology. International Journal of Cardiology, 153(3), 239-240. [More Information]
  • Ambrosio, G., Flather, M., Bohm, M., Cohen-Solal, A., Murrone, A., Mascagni, F., Spinucci, G., Conti, M., Van Veldhuisen, D., Tavazzi, L., Coats, A. (2011). β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure. E-Heart, 97(3), 209-214. [More Information]
  • Kalra, P., Clague, J., Coats, A., Anker, S., Poole-Wilson, P., Struthers, A. (2010). C-type Natriuretic Peptide Production by the Human Kidney is Blunted in Chronic Heart Failure. Clinical Science, 118, 71-77. [More Information]
  • Shewan, L., Coats, A. (2010). Ethics in the authorship and publishing of scientific articles. International Journal of Cardiology, 144(1), 1-2. [More Information]
  • Davies, E., Moxham, T., Rees, K., Singh, S., Coats, A., Ebrahim, S., Lough, F., Taylor, R. (2010). Exercise Training for Systolic Heart Failure: Cochrane Systematic Review and Meta-Analysis. European Journal of Heart Failure, 12(7), 706-715. [More Information]
  • Ng, A., Davis, G., Chow, C., Coats, A., Sindone, A., Freedman, B. (2010). Impact of sleep disordered breathing severity on hemodynamics, autonomic balance and cardiopulmonary functional status in chronic heart failure. International Journal of Cardiology, 141(3), 227-235. [More Information]
  • de Boer, R., Doehner, W., van der Horst, I., Anker, S., Babalis, D., Roughton, M., Coats, A., Flather, M., van Veldhuisen, D. (2010). Influence of Diabetes Mellitus and Hyperglycemia on Prognosis in Patients >70 Years Old With Heart Failure and Effects of Nebivolol (Data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure [SENIORS]). The American Journal of Cardiology, 106(1), 78-86.e1. [More Information]
  • Barron, A., Medlow, K., Giannoni, A., Unsworth, B., Coats, A., Mayet, J., Howard, L., Francis, D. (2010). Reduced Confounding by Impaired Ventilatory Function With Oxygen Uptake Efficiency Slope and VE/VCO(2) Slope Rather Than Peak Oxygen Consumption to Assess Exercise Physiology in Suspected Heart Failure. Congestive Heart Failure, 16(6), 259-264. [More Information]
  • Coats, A. (2010). Retraction of a paper containing plagiarized material: The prognostic value of serum troponin T in unstable angina. G??khan Cin V, G??k H, Kaptano??lu B. Int J Cardiol. 1996 Mar;53(3):237-44. International Journal of Cardiology, 145(3), e81-2. [More Information]
  • van Veldhuisen, D., Cohen-Solal, A., Bohm, M., Anker, S., Babalis, D., Roughton, M., Coats, A., Poole-Wilson, P., Flather, M. (2009). Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). Journal of the American College of Cardiology, 53(23), 2150-2158. [More Information]
  • Cohen-Solal, A., Kotecha, D., van Veldhuisen, D., Babalis, D., Bohm, M., Coats, A., Roughton, M., Poole-Wilson, P., Tavazzi, L., Flather, M. (2009). Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial. European Journal of Heart Failure, 11(9), 872-880. [More Information]
  • Coats, A. (2008). Ethical authorship and publishing. International Journal of Cardiology, 131(2), 149-50. [More Information]
  • Yao, G., Freemantle, N., Flather, M., Tharmanathan, P., Coats, A., Poole-Wilson, P. (2008). Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure An Individual Patient-Based Simulation Model. PharmacoEconomics, 26(10), 879-889. [More Information]
  • Coats, A. (2008). Retraction of “Xue SR. Xue Y. Xue R. Carvedilol restore cardiac calcium release channel structure and function in heart failure. Int. J Cardiology. 116(2):231-5, 2007�? containing plagiarised material. International Journal of Cardiology, 125(3), 293-293. [More Information]
  • Coats, A., Williamson, E. (2008). Scientific deception: Retraction of a fraudulent paper. International Journal of Cardiology, 131, 297. [More Information]
  • Coats, A. (2008). The top papers by download and citations from the International Journal of Cardiology in 2007. International Journal of Cardiology, 131(1), e1-3. [More Information]
  • Ponikowski, P., Anker, S., Szachniewicz, J., Okonko, D., Ledwidge, M., Zymlinski, R., Ryan, E., Wasserman, S., Baker, N., Coats, A., et al (2007). Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. Journal of the American College of Cardiology, 49(7), 753-762. [More Information]
  • Clark, A., Knosalla, C., Birks, E., Loebe, M., Davos, C., Tsang, S., Negassa, A., Yacoub, M., Hetzer, R., Coats, A., et al (2007). Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes. European Journal of Heart Failure, 9(8), 839-844. [More Information]
  • Piepoli, M., Coats, A. (2007). Increased metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. Journal of Applied Physiology, 102(1), 494-497. [More Information]
  • Dobre, D., van Veldhuisen, D., Mordenti, G., Vintila, M., Haaijer-Ruskamp, F., Coats, A., Poole-Wilson, P., Flather, M. (2007). Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial. American Heart Journal, 154(1), 109-115. [More Information]
  • Szollosi, I., O'driscoll, D., Dayer, M., Coats, A., Morrell, M., Simonds, A. (2006). Adaptive servo-ventilation and deadspace: effects on central sleep apnoea. Journal of Sleep Research, 15(2), 199-205. [More Information]
  • Krum, H., Mohacsi, P., Katus, H., Tendera, M., Rouleau, J., Fowler, M., Coats, A., Roecker, E., Packer, M., Carvedilol, S. (2006). Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study. American Heart Journal, 151(1), 55-61. [More Information]
  • Coats, A. (2006). Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents. Drugs and Aging, 23(2), 93-99. [More Information]
  • Dawes, M., Coats, A., Juszczak, E. (2006). Daytime ambulatory systolic blood pressure is more effective at predicting mortality than clinic blood pressure. Blood pressure monitoring, 11(3), 111-118. [More Information]
  • Faris, R., Flather, M., Purcell, H., Poole-Wilson, P., Coats, A. (2006). Diuretics for heart failure. Cochrane Database of Systematic Reviews, 1(1), 3838-3838. [More Information]
  • Davies, L., Wensel, R., Georgiadou, P., Cicoira, M., Coats, A., Piepoli, M., Francis, D. (2006). Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. European Heart Journal, 27(6), 684-690. [More Information]
  • Thomas, M., Fox, K., Coats, A. (2006). Redefining heart failure. International Journal of Cardiology, 112(2), 139-141. [More Information]
  • Rao, A., Georgiadou, P., Francis, D., Johnson, A., Kremastinos, D., Simonds, A., Coats, A., Cowley, A., Morrell, M. (2006). Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms. Journal of Sleep Research, 15(1), 81-88. [More Information]
  • Anker, S., Clark, A., Winkler, R., Zugck, C., Cicoira, M., Ponikowski, P., Davos, C., Banasiak, W., Zardini, P., Haass, M., Coats, A., et al (2006). Statin use and survival in patients with chronic heart failure - results from two observational studies with 5200 patients. International Journal of Cardiology, 112(2), 234-242. [More Information]
  • Genth-Zotz, S., von Haehling, S., Bolger, A., Kalra, P., Wensel, R., Coats, A., Volk, H., Anker, S. (2006). The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure. European Journal of Heart Failure, 8(4), 366-372. [More Information]
  • McLean, A., Eslick, G., Coats, A. (2006). The epidemiology of heart failure in Australia. International Journal of Cardiology, 118(3), 370-374. [More Information]
  • Shewan, L., Coats, A. (2006). The Research Quality Framework and its implications for health and medical research: time to take stock? Medical Journal of Australia, 184(9), 463-466. [More Information]
  • Coats, A. (2005). Advances in the non-drug, non-surgical, non-device management of chronic heart failure. International Journal of Cardiology, 100(1), 1-4. [More Information]
  • Okonko, D., Crosato, M., Kalra, P., Cicoira, M., John, M., Doehner, W., Coats, A., Poole-Wilson, P., Anker, S. (2005). Association of deranged adrenal steroid metabolism with anemia in chronic heart failure. The American Journal of Cardiology, 96(1), 101-103. [More Information]
  • Stewart, S., McMurray, J., Hebborn, A., Coats, A., Packer, M. (2005). Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom. International Journal of Cardiology, 100(1), 143-149. [More Information]
  • Sharma, R., Bolger, A., Rauchhaus, M., von Haehling, S., Doehner, W., Adcock, I., Barnes, P., Poole-Wilson, P., Volk, H., Coats, A., et al (2005). Cellular endotoxin desensitization in patients with severe chronic heart failure. European Journal of Heart Failure, 7(5), 865-868. [More Information]
  • Rossi, A., Cicoira, M., Florea, V., Golia, G., Florea, N., Khan, A., Murray, S., Nguyen, J., O'Callaghan, P., Coats, A., et al (2005). Chronic heart failure with preserved left ventricular ejection fraction: Diagnostic and prognostic value of left atrial size. International Journal of Cardiology, 110(3), 386-392. [More Information]
  • Shewan, L., Glatz, J., Bennett, C., Coats, A. (2005). Contemporary (post-Wills) survey of the views of Australian medical researchers: importance of funding, infrastructure and motivators for a research career. Medical Journal of Australia, 183(11/12), 606-611. [More Information]
  • Coats, A. (2005). Dyspnoea in CHF and COPD. International Journal of Cardiology, 105(3), 351-351. [More Information]
  • Thomas, M., Fox, K., Wood, D., Gibbs, J., Coats, A., Henein, M., Poole-Wilson, P., Sutton, G. (2005). Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function. Heart, 92(5), 603-608. [More Information]
  • Wensel, R., Francis, D., Georgiadou, P., Scott, A., Genth-Zotz, S., Anker, S., Coats, A., Piepoli, M. (2005). Exercise hyperventilation in chronic heart failure is not caused by systemic lactic acidosis. European Journal of Heart Failure, 7(7), 1105-1111. [More Information]
  • Niebauer, J., Clark, A., Webb-Peploe, K., Coats, A. (2005). Exercise training in chronic heart failure: effects on pro-inflammatory markers. European Journal of Heart Failure, 7(2), 189-193. [More Information]
  • Coats, A. (2005). Five years of progress for international journal of cardiology. International Journal of Cardiology, 100(1), 173-175. [More Information]
  • Niebauer, J., Clark, A., Webb-Peploe, K., Böger, R., Coats, A. (2005). Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure. European Journal of Heart Failure, 7(2), 183-188. [More Information]
  • Doehner, W., Rauchhaus, M., Ponikowski, P., Godsland, I., von Haehling, S., Okonko, D., Leyva, F., Proudler, A., Coats, A., Anker, S. (2005). Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. Journal of the American College of Cardiology, 46(6), 1019-1026. [More Information]
  • Kalantar-Zadeh, K., Anker, S., Coats, A., Horwich, T., Fonarow, G. (2005). Obesity paradox as a component of reverse epidemiology in heart failure. Archives of Internal Medicine, 165(15), 1797; author reply 1797-8. [More Information]
  • Edmonds, P., Rogers, A., Addington-Hall, J., McCoy, A., Coats, A., Gibbs, J. (2005). Patient descriptions of breathlessness in heart failure. International Journal of Cardiology, 98(1), 61-66. [More Information]
  • Flather, M., Shibata, M., Coats, A., Van Veldhuisen, D., Parkhomenko, A., Borbola, J., Cohen-Solal, A., Dumitrascu, D., Ferrari, R., Lechat, P., et al (2005). Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). European Heart Journal, 26(3), 215-225. [More Information]
  • Kalantar-Zadeh, K., Anker, S., Coats, A., Horwich, T., Fonarow, G. (2005). Reply: Obesity paradox as a component of reverse epidemiology in heart failure. Archives of Internal Medicine, , 1797-1798.
  • Sharma, R., Tigas, S., Rauchhaus, M., Poole-Wilson, P., Coats, A., Umpleby, M., Carroll, A., Anker, S. (2005). Substrate metabolism in patients with chronic heart failure with and without cachexia. Circulation, 112, U660-U660.
  • Coats, A. (2005). Top of the charts: download versus citations in the International Journal of Cardiology. International Journal of Cardiology, 105(2), 123-125. [More Information]
  • Sharma, R., von Haehling, S., Rauchhaus, M., Bolger, A., Genth-Zotz, S., Doehner, W., Oliver, B., Poole-Wilson, P., Hans-Dieter, V., Coats, A., et al (2005). Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins. European Journal of Heart Failure, 7(4), 479-484. [More Information]
  • Coats, A. (2005). Why ventilatory inefficiency matters in chronic heart failure. European Heart Journal, 26(5), 426-427. [More Information]
  • Coats, A. (2004). Anaemia and heart failure. Heart, 90, 977-979.
  • Onwuamaegbu, M., Henein, M., Coats, A. (2004). Cachexia In Malaria And Heart Failure: Therapeutic Considerations In Clinical Practice. Postgraduate Medical Journal, 80(949), 642-649.
  • Kerr, J., Cunniffe, V., Kelleher, P., Coats, A., Mattey, D. (2004). Circulating Cytokines And Chemokines In Acute Symptomatic Parvovirus B19 Infection: Negative Association Between Levels Of Pro-Inflammatory Cytokines And Development Of B19-Associated Arthritis. Journal of Medical Virology, 74(1), 147-155. [More Information]
  • Wensel, R., Georgiadou, P., Francis, D., Bayne, S., Scott, A., Genth-Zotz, S., Anker, S., Coats, A., Piepoli, M. (2004). Differential Contribution Of Dead space Ventilation And Low Arterial Pco2 To Exercise Hyperpnea In Patients With Chronic Heart Failure Secondary To Ischemic Or Idiopathic Dilated Cardiomyopathy. The American Journal of Cardiology, 93(3), 318-323. [More Information]
  • Szollosia, I., Jones, M., Morrell, M., Helfetb, K., Coats, A., Simonds, A. (2004). Effect Of Co₂ Inhalation On Central Sleep Apnea And Arousals From Sleep. Respiration, 71(5), 493-498.
  • Bellenger, N., Rajappan, K., Rahman, S., Lahiri, A., Raval, U., Webster, J., Murray, G., Coats, A., Cleland, J., Pennell, D. (2004). Effects Of Carvedilol On Left Ventricular Remodelling In Chronic Stable Heart Failure: A Cardiovascular Magnetic Resonance Study. Heart, 90(7), 760-764.
  • Rees, K., Taylor, R., Singh, S., Coats, A., Ebrahim, S. (2004). Exercise Based Rehabilitation For Heart Failure. Cochrane Database of Systematic Reviews, 2004 (3), CD003331.
  • Piepoli, M., Davos, C., Francis, D., Coats, A. (2004). Exercise Training Meta-Analysis Of Trials In Patients With Chronic Heart Failure (Extramatch). BMJ: British Medical Journal, 328(7433), 189-195.
  • Sharma, R., Francis, D., Pitt, B., Poole-Wilson, P., Coats, A., Anker, S. (2004). Haemoglobin Predicts Survival In Patients With Chronic Heart Failure: A Substudy Of The Elite Ii Trial. European Heart Journal, 25(12), 1021-1028. [More Information]
  • Genth-Zotz, S., Bolger, A., Kalra, P., von Haehling, S., Doehner, W., Coats, A., Volk, H., Anker, S. (2004). Heat Shock Protein 70 In Patients With Chronic Heart Failure: Relation To Disease Severity And Survival. International Journal of Cardiology, 96(3), 397-401. [More Information]
  • Rouleau, J., Roecker, E., Tendera, M., Mohacsi, P., Krum, H., Katus, H., Fowler, M., Coats, A., Castaigne, A., Scherhag, A., et al (2004). Influence Of Pretreatment Systolic Blood Pressure On The Effect Of Carvedilol In Patients With Severe Chronic Heart Failure: The Carvedilol Prospective Randomized Cumulative Survival (Copernicus) Study. Journal of the American College of Cardiology, 43(8), 1423-1429. [More Information]
  • Collinson, J., Flather, M., Coats, A., Pepper, J., Henein, M. (2004). Influence Of Valve Prosthesis Type On The Recovery Of Ventricular Dysfunction And Subendocardial Ischaemia Following Valve Replacement For Aortic Stenosis. International Journal of Cardiology, 97(3), 535-541.
  • Rosen, S., Murphy, K., Leff, A., Cunningham, V., Wise, R., Adams, L., Coats, A., Camici, P. (2004). Is Central Nervous System Processing Altered In Patients With Heart Failure? European Heart Journal, 25(11), 952-962. [More Information]
  • Salukhe, T., Dimopoulos, K., Sutton, R., Coats, A., Piepoli, M., Francis, D. (2004). Life-Years Gained From Defibrillator Implantation: Markedly Nonlinear Increase During 3 Years Of Follow-Up And Its Implications. Circulation, 109(15), 1848-1853.
  • Dimopoulos, K., Salukhe, T., Coats, A., Piepoli, M., Mayet, J., Francis, D. (2004). Meta-Analyses Of Mortality And Morbidity Effects Of An Angiotensin Receptor Blocker In Patients With Chronic Heart Failure Already Receiving An Ace Inhibitor (Alone Or With A Beta-Blocker). International Journal of Cardiology, 93(2-3), 105-111. [More Information]
  • Hartmann, F., Packer, M., Coats, A., Fowler, M., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Castaigne, A., Trawinski, J., et al (2004). Nt-Probnp In Severe Chronic Heart Failure: Rationale, Design And Preliminary Results Of The Copernicus Nt-Probnp Substudy. European Journal of Heart Failure, 6(3), 343-350. [More Information]
  • Cicoira, M., Davos, C., Francis, D., Doehner, W., Zanolla, L., Franceschini, L., Piepoli, M., Zardini, P., Coats, A., Poole-Wilson, P., et al (2004). Prediction Of Mortality In Chronic Heart Failure From Peak Oxygen Consumption Adjusted For Either Body Weight Or Lean Tissue. Journal of Cardiac Failure, 10(5), 421-426. [More Information]
  • Hartmann, F., Packer, M., Coats, A., Fowler, M., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Castaigne, A., et, A. (2004). Prognostic Impact Of Plasma N-Terminal Pro-Brain Natriuretic Peptide In Severe Chronic Congestive Heart Failure: A Substudy Of The Carvedilol Prospective Randomized Cumulative Survival (Copernicus) Trial. Circulation, 110(13), 1780-1786.
  • Scott, A., Wensel, R., Davos, C., Georgiadou, P., Davies, L., Coats, A., Francis, D., Piepoli, M. (2004). Putative Contribution Of Prostaglandin And Bradykinin To Muscle Reflex Hyperactivity In Patients On Ace-Inhibitor Therapy For Chronic Heart Failure. European Heart Journal, 25(20), 1806-1813. [More Information]
  • Thomas, M., Fox, K., Coats, A., Sutton, G. (2004). The Epidemiological Enigma Of Heart Failure With Preserved Systolic Function. European Journal of Heart Failure, 6(2), 125-136. [More Information]
  • Florea, V., Moon, J., Pennell, D., Doehner, W., Coats, A., Anker, S. (2004). Wasting Of The Left Ventricle In Patients With Cardiac Cachexia: A Cardiovascular Magnetic Resonance Study. International Journal of Cardiology, 97(1), 15-20. [More Information]
  • Coats, A. (2003). Adult congenital heart disease in the international journal of cardiology. International Journal of Cardiology, 11, 125-126.
  • Scott, A., Roe, N., Coats, A., Piepoli, M. (2003). Aerobic exercise physiology in a professional rugby union team. International Journal of Cardiology, 87(2-3), 173-177.
  • Davos, C., Doehner, W., Rauchhaus, M., Cicoira, M., Francis, D., Coats, A., Clark, A., Anker, S. (2003). Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. Journal of Cardiac Failure, 9(1), 29-35.
  • Bolger, A., Coats, A., Gatzoulis, M. (2003). Congenital heart disease: the original heart failure syndrome. European Heart Journal, 24(10), 970-976.
  • McCrohon, J., Moon, J., Prasad, S., McKenna, W., Lorenz, C., Coats, A., Pennell, D. (2003). Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation, 108, 54-59.
  • Kalra, P., Bolger, A., Francis, D., Genth-Zotz, S., Sharma, R., Ponikowski, P., Poole-Wilson, P., Coats, A., Anker, S. (2003). Effect of anemia on exercise tolerance in chronic heart failure in men. The American Journal of Cardiology, 91, 888-891.
  • Al-Nasser, F., Yousufuddin, M., Al-Nozha, F., Anker, S., Coats, A., Piepoli, M., Ponikowski, P. (2003). Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern. The American Journal of Cardiology, 91(10), 1281-1283.
  • Krum, H., Roecker, E., Mohacsi, P., Rouleau, J., Tendera, M., Coats, A., Katus, H., Fowler, M., Packer, M. (2003). Effects of Initiating Carvedilol in Patients With Severe Chronic Heart Failure. JAMA: The Journal of the American Medical Association, 289(6 (reprinted)), 712-718. [More Information]
  • Sharma, R., Bolger, A., Li, W., Davlouros, P., Volk, H., Poole-Wilson, P., Coats, A., Gatzoulis, M., Anker, S. (2003). Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congential heart disease. The American Journal of Cardiology, 92(2), 188-193.
  • Davos, C., Francis, D., Leenarts, M., Yap, S., Li, W., Davlouros, P., Wensel, R., Coats, A., Piepoli, M., Sreeram, N., et al (2003). Global impairment of cardiac autonomic nervous activity late after the fontan operation. Circulation, 108(supp II), II-180-II-185.
  • Kalra, P., Collier, T., Cowie, M., Fox, K., Wood, D., Poole-Wilson, P., Coats, A., Sutton, G. (2003). Haemoglobin concentration and prognosis in new cases of heart failure. The Lancet, 362(9379), 211-212.
  • Crisafulli, A., Scott, A., Wensel, R., Davos, C., Francis, D., Pagliaro, P., Coats, A., Concu, A., Piepoli, M. (2003). Muscle metaboreflex-induced increases in stroke volume. Medicine and Science in Sports and Exercise, 35(2), 221-228.
  • Kalra, P., Clague, J., Bolger, A., Anker, S., Poole-Wilson, P., Struthers, A., Coats, A. (2003). Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation, 107(4), 571-573.
  • Cleland, J., Pennell, D., Coats, A., Ray, S., Macfarlane, P., Murray, G., Dalle Mule, J., Vered, Z., Lahiri, A. (2003). Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure( CHRISTMAS trial): randomized controlled trial. The Lancet, 362(9377), 14-21.
  • Anker, S., Negassa, A., Coats, A., Afzal, R., Poole-Wilson, P., Cohn, J., Yusuf, S. (2003). Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. The Lancet, 361(9363), 1077-1083.
  • Russell, S., Selaru, P., Pyne, D., Ghazzi, M., Massey, K., Pressler, M., Serikoff, A., Coats, A. (2003). Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Excerise) trial. American Heart Journal, 145(1), 179-186.
  • Scott, A., Francis, D., Coats, A., Piepoli, M. (2003). Reproducibility of the measurement of the muscle ergoreflex activity in chronic heart failure. European Journal of Heart Failure, 5(4), 453-461.
  • Williams, S., Wright, D., Marshall, P., Reese, A., Tzeng, B., Coats, A., Tan, L. (2003). Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart, 89(9), 1085-1086.
  • Scott, A., Wensel, R., Davos, C., Georgiadou, P., Kemp, M., Hooper, J., Coats, A., Piepoli, M. (2003). Skeletal muscle reflex in heart failure patients: Role of hydrogen. Circulation, 107, 300-306.
  • von Haehling, S., Genth-Zotz, S., Sharma, R., Bolger, A., Doehner, W., Barnes, P., Coats, A., Anker, S. (2003). The relationship between age and production of tumour necrosis factor- alpha in healthy volunteers and patients with chronic heart failure. International Journal of Cardiology, 90(2-3), 197-204.
  • Rauchhaus, M., Clark, A., Doehner, W., Davos, C., Bolger, A., Sharma, R., Coats, A., Anker, S. (2003). The relationship between cholesterol and survival in patients with chronic heart failure. Journal of the American College of Cardiology, 42(11), 1933-1940. [More Information]
  • Anker, S., Doehner, W., Rauchhaus, M., Sharma, R., Francis, D., Knosalla, C., Davos, C., Cicoira, M., Shamim, W., Kemp, M., Coats, A., et al (2003). Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional and hemodynamic staging. Circulation, 107, 1991-1997.
  • Coats, A. (2003). Use of carvedilol in the treatment of heart failure. British Journal of Hospital Medicine, 64(5), 288-291.
  • Halamek, J., Kara, T., Jurak, P., Soucek, M., Francis, D., Davies, L., Shen, W., Coats, A., Novak, M., Novakova, Z., et al (2003). Variability of phase shift between blood pressure and heart rate fluctuations. A marker of short-term circulation control. Circulation, 108, 292-297.
  • Faris, R., Henein, M., Coats, A. (2003). Ventricular long axis function is predictive of outcome in patients with chronic heart failure secondary to non-ischemic dilated cardiomyopathy. Medical Science Monitor, 9(11), 456-465.
  • Davies, L., Colhoun, H., Coats, A., Piepoli, M., Francis, D. (2002). A noninvasive measure of baroreflex sensitivity without blood pressure measurement. American Heart Journal, 143(3), 441-447.
  • Rogers, A., Addington-Hall, J., McCoy, A., Edmonds, P., Abery, A., Coats, A., Gibbs, J. (2002). A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. European Journal of Heart Failure, 4(3), 283-287.
  • Davies, L., Francis, D., Wilson, K., Scott, A., Piepoli, M., Coats, A. (2002). Abnormal temporal dynamics of blood pressure and RR interval regulation in patients with chronic heart failure: relationship to baroreflex sensitivity. International Journal of Cardiology, 86(1), 107-114.
  • Coats, A. (2002). Angiotensin type-1 receptor blockers in heart failure. Progress In Cardiovascular Diseases, 44(4), 231-242.
  • Al-Nasser, F., Duncan, A., Sharma, R., O'Sullivan, C., Coats, A., Anker, S., Henein, M. (2002). Beta-blocker therapy for dynamic left-ventricular outflow tract obstruction. International Journal of Cardiology, 86(2-3), 199-205.
  • Scott, A., Davos, C., Wensel, R., Kemp, M., Kaczmarek, A., Hooper, J., Coats, A., Piepoli, M. (2002). Chemical mediators of the muscle ergoreflex in chronic heart failure - A putative role for prostaglandins in reflex ventilatory control. Circulation, 106(2), 214-220.
  • Kalra, P., Sharma, R., Shamim, W., Doehner, W., Wensel, R., Bolger, A., Genth-Zotz, S., Cicoira, M., Coats, A., Anker, S. (2002). Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. International Journal of Cardiology, 86(2-3), 225-231.
  • Faris, R., Purcell, H., Henein, M., Coats, A. (2002). Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. European Journal of Heart Failure, 4, 541-551.
  • Faris, R., Flather, M., Purcell, H., Henein, M., Poole-Wilson, P., Coats, A. (2002). Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. International Journal of Cardiology, 82(2), 149-158.
  • Moon, J., Kalra, P., Coats, A. (2002). DANAMI-2: Is primary angioplasty superior to thrombolysis in acute MI when the patient has to be transferred to an invasive centre? International Journal of Cardiology, 85(2-3), 199-201.
  • Kalra, P., Moon, J., Coats, A. (2002). Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? International Journal of Cardiology, 85(2-3), 195-197.
  • Miller, A., O'Connor, C., Coats, A., Krum, H., Tendera, M., Mohasci, P., Rouleau, J., Fowler, M., Katus, H., Roecker, E., et al (2002). Does digitalis influence the response to beta-blockade in patients with severe chronic heart failure? Results of the COPERNICUS study. Journal of the American College of Cardiology, 39(Supplement 1), 166A-166A.
  • Mohacsi, P., Krum, H., Rouleau, J., Fowler, M., Katus, H., Coats, A., Tendera, M., Amann-Zalan, I., Roecker, E., Packer, M. (2002). Does the degree of interference with the renin-angiotensin system influence the response to B-blockade in chronic heart failure? Results of the COPERNICUS study. Journal of the American College of Cardiology, 39(Supplement 1), 167A-167A.
  • Faris, R., Coats, A., Henein, M. (2002). Echocardiography-derived variables predict outcome in patients with nonischemic dilated cardiomyopathy with or without a restrictive filling pattern. American Heart Journal, 144(2), 343-350.
  • Packer, M., Fowler, M., Roecker, E., Coats, A., Katus, H., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Staiger, C., et al (2002). Effect of carvedilol on the morbidity of patients with severe chronic heart failure - Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. Circulation, 106(17), 2194-2199.
  • Tendera, M., Coats, A., Fowler, M., Katus, H., Mohacsi, P., Rouleau, J., Krum, H., Amann-Zalan, I., Shusterman, N., Roecker, E. (2002). Effect of gender on the outcome of patients with severe heart failure treated with carvedilol: Results of the COPERNICUS study. Journal of the American College of Cardiology, 39(Supplement 1), 185A-185A.
  • Bolger, A., Sharma, R., von Haehling, S., Doehner, W., Oliver, B., Rauchhaus, M., Coats, A., Adcock, I., Anker, S. (2002). Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. The American Journal of Cardiology, 90(4), 384-389.
  • Doehner, W., Schoene, N., Rauchhaus, M., Leyva-Leon, F., Pavitt, D., Reaveley, D., Schuler, G., Coats, A., Anker, S., Hambrecht, R. (2002). Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies. Circulation, 105(22), 2619-2624.
  • Rouleau, J., Fowler, M., Krum, H., Katus, H., Coats, A., Tendera, M., Mohacsi, P., Amann-Zalan, I., Holcslaw, T., Roecker, E., et al (2002). Efficacy and safety of carvedilol in patients with severe chronic heart failure and low systolic blood pressure: Results of the COPERNICUS study. Journal of the American College of Cardiology, 39(Supplement 1), 171A-172A.
  • Davos, C., Davlouros, P., Wensel, R., Francis, D., Davies, L., Kilner, P., Coats, A., Piepoli, M., Gatzoulis, M. (2002). Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation, 106(Supplement 1), I-69-I-75.
  • Cowie, M., Fox, K., Wood, D., Metcalfe, C., Thompson, S., Coats, A., Poole-Wilson, P., Sutton, G. (2002). Hospitalization of patients with heart failure - A population-based study. European Heart Journal, 23(11), 877-885.
  • Anker, S., Coats, A. (2002). How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. International Journal of Cardiology, 86(2-3), 123-130.
  • Kalra, P., Genth-Zotz, S., Coats, A., Anker, S. (2002). Human pituitary growth hormone and cancer risk. The Lancet, 360(9347), 1791-1792.
  • Shamim, W., Yousufuddin, M., Cicoira, M., Gibson, D., Coats, A., Henein, M. (2002). Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart, 88(1), 47-51.
  • Faris, R., Henein, M., Coats, A. (2002). Influence of gender and alcohol on mortality in nonischemic dilated cardiomyopathy. Journal of the American College of Cardiology, 39(Sup.1), 144-144.
  • Doehner, W., Rauchhaus, M., Godsland, I., Egerer, K., Niebauer, J., Sharma, R., Cicoira, M., Florea, V., Coats, A., Anker, S. (2002). Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. International Journal of Cardiology, 83(1), 73-81.
  • Yousufuddin, M., Shamim, W., Flather, M., Amrani, M., Coats, A. (2002). Inter-relationship of endothelin-1 and natriuretic peptide secretory responses to acute exercise in patient with chronic heart failure and healthy controls. Journal of the American College of Cardiology, 39(Supplement 1), 147-147.
  • Krum, H., Mohacsi, P., Katus, H., Tendera, M., Rouleau, J., Fowler, M., Coats, A., Roecker, E., Packer, M. (2002). Is additional neurohormonal antagonism useful in patients with severe chronic heart failure already receiving a combination of neurohormonal antagonists? Results of the COPERNICUS study. Journal of the American College of Cardiology, 39(Supplement 1), 177A-178A.
  • Yousufuddin, M., Amrani, M., Shamim, W., Al-Nasser, F., Amin, F., Banner, N., Coats, A. (2002). L-arginine for partial resynchronization of abnormal peripheral vascular reactivity in heart failure: A prospective randomized double-blind study. Journal of the American College of Cardiology, 39(Supplement 2), 452A-452A.
  • Cicoira, M., Davos, C., Doehner, W., Franceschini, L., Zanolla, L., Coats, A., Zardini, P., Anker, S. (2002). Lean tissue-adjusted versus body weight-adjusted peak oxygen consumption and mortality prediction in chronic heart failure. Journal of the American College of Cardiology, 39(1), 148-148.
  • Coats, A. (2002). MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials? International Journal of Cardiology, 82(1), 1-5.
  • Bolger, A., Sharma, R., Li, W., Leenarts, M., Kalra, P., Kemp, M., Coats, A., Anker, S., Gatzoulis, M. (2002). Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation, 106(1), 92-99.
  • Coats, A. (2002). Omapatrilat - the story of Overture and Octave. International Journal of Cardiology, 86(1), 1-4.
  • Coats, A. (2002). Origin of symptoms in patients with cachexia with special reference to weakness and shortness of breath. International Journal of Cardiology, 85(1), 133-139.
  • Corra, U., Giordano, A., Bosimini, E., Mezzani, A., Piepoli, M., Coats, A., Giannuzzi, P. (2002). Oscillatory ventilation during exercise in patients with chronic heart failure - Clinical correlates and prognostic implications. Chest, 121(5), 1572-1580.
  • Genth-Zotz, S., von Haehling, S., Bolger, A., Kalra, P., Wensel, R., Coats, A., Anker, S. (2002). Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. The American Journal of Cardiology, 90(11), 1226-1230.
  • Adamopoulos, S., Parissis, J., Karatzas, D., Kroupis, C., Georgiadis, M., Karavolias, G., Paraskevaidis, J., Koniavitou, K., Coats, A., Kremastinos, D. (2002). Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. Journal of the American College of Cardiology, 39(4), 653-663.
  • Hartmann, F., Richardt, G., Packer, M., Coats, A., Fowler, M., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Castaigne, A., et al (2002). Plasma N-terminal pro-BNP predicts the occurrence of major clinical events in severe chronic heart failure: Results of a substudy of the COPERNICUS trial. Journal of the American College of Cardiology, 39(Supplement 1), 200A-200A.
  • Coats, A. (2002). Positive inotropy for acute heart failure complicating myocardial infarction. European Heart Journal, 23(18), 1405-1406.
  • Cleland, J., Penneli, D., Webster, J., Ray, S., Bhattacharya, A., Coats, A., Lahiri, A., Macfarlane, P., Mule, J., Vered, Z., et al (2002). Prevalence of hibernating myocardium and reversible silent myocardial ischemia in patients with heart failure due to coronary artery disease: Baseline data from the CHRISTMAS study. Journal of the American College of Cardiology, 39(Suppl 1), 187A-187A.
  • Wilson, K., Francis, D., Wensel, R., Coats, A., Parker, K. (2002). Relationship between detrended fluctuation analysis and spectral analysis of heart-rate variability. Physiological Measurement, 23(2), 385-401.
  • Scott, A., Davies, L., Coats, A., Piepoli, M. (2002). Relationship of skeletal muscle metaboreceptors in the upper and lower limbs with the respiratory control in patients with heart failure. Clinical Science, 102(1), 23-30.
  • Shamim, W., Yousufuddin, M., Xiao, H., Flather, M., Henein, M., Gibson, D., Coats, A. (2002). Septal q waves as an indicator of risk of mortality in elderly patients with chronic heart failure. American Heart Journal, 144(4), 740-744.
  • Shibata, M., Flather, M., Bohm, M., Borbola, J., Cohen-Solal, A., Dumitrascu, D., Ferrari, R., Lechat, P., Parkhomenko, A., Coats, A., et al (2002). Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design. International Journal of Cardiology, 86(1), 77-85.
  • Florea, V., Henein, M., Rauchhaus, M., Koloczek, V., Sharma, R., Doehner, W., Poole-Wilson, P., Coats, A., Anker, S. (2002). The cardiac component of cardiac cachexia. American Heart Journal, 144(1), 45-50.
  • Cleland, J., Pennell, D., Ray, S., Coats, A., Lahri, A., Macfarlane, P., Mule, J., Vered, Z., Murray, G. (2002). The Carvedilol Hibernation Reversible Ischemia Trial: Marker of success (CHRISTMAS). Journal of the American College of Cardiology, 39(Supplement 1), 172A-172A.
  • Rauchhaus, M., Gross, M., Schultz, S., Francis, D., Greiser, P., Norwig, A., Weidhase, L., Coats, A., Dietz, R., Anker, S., et al (2002). The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty. International Journal of Cardiology, 83(3), 249-257.
  • Coats, A. (2002). The metabolic extension of research in cardiology into the better understanding of cachexia: role of the International Journal of Cardiologyi - Preface. International Journal of Cardiology, 85(1), 1-3.
  • Kalra, P., Anagnostopoulos, C., Bolger, A., Coats, A., Anker, S. (2002). The regulation and measurement of plasma volume in heart failure. Journal of the American College of Cardiology, 39(12), 1901-1908.
  • Coats, A. (2002). Treatment of heart failure. Hospital Medicine: for primary care physicians, 63(8), 497-497.
  • Coats, A. (2002). What do Cochrane reviews tell us about anti-thrombotic therapy in heart failure with sinus rhythm? QJM, 95(7), 419-421.
  • Scott, A., Francis, D., Davies, L., Coats, A., Piepoli, M. (2001). A novel treadmill exercise test protocol with improved metabolic plateau formation. European Heart Journal, , 195-195.
  • Yousufuddin, M., Flather, M., Shamim, W., Yousef, Z., Marber, M., Amrani, M., Banner, N., Kemp, M., Hooper, J., Coats, A. (2001). A short course of l-arginine improves exercise capacity and endothelial function in chronic heart failure: A prospective, randomised, double blind trial. Journal of the American College of Cardiology, , 211A-211A.
  • Coats, A. (2001). A sympathetic heart and the art of dying. European Heart Journal, 22, 1069-1071.
  • Anker, S., Volterrani, M., Pflaum, C., Strasburger, C., Osterziel, K., Doehner, W., Ranke, M., Poole-Wilson, P., Giustina, A., Dietz, R., Coats, A. (2001). Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone. Journal of the American College of Cardiology, 38, 443-452.
  • Coats, A. (2001). Angiotensin Receptor Blockers - finally the evidence is coming in: IDNT and RENAAL. International Journal of Cardiology, 79, 99-102.
  • Parissis, J., Adamopoulos, S., Karatzas, D., Kroupis, C., Georgiadis, M., Karavolias, G., Koniavitou, K., Karas, S., Coats, A. (2001). Anti-inflammatory effects of physical training are associated with improvement in endothelial function of chronic heart failure patients. European Heart Journal, , 684-684.
  • Bolger, A., Rashid, M., Rauchhaus, M., Sharma, R., Doehner, W., Stephens,, R., Kemp, M., Barclay, G., Coats, A., Anker, S. (2001). Antiendotoxin core antibody levels and endotoxin exposure in non-oedematous severe chronic heart failure. European Heart Journal, , 48-48.
  • Schmidt, H., Rauchhaus, M., Francis, D., Davis, C., Nuding, S., Peschel, T., Schmidt, D., Coats, A., Opitz, H., Werdan, K. (2001). Assessment of chemoreflex sensitivity in free breathing young subjects by correction for respiratory influence. European Heart Journal, 78, 157-165.
  • Yousufuddin, M., Henein, M., Flather, M., Shamim, W., Al-Nasser, F., Kemp, M., Hooper, J., Banner, N., Amrani, M., Coats, A. (2001). Atrial natriuretic peptide compensates for the attenuated brain natriuretic peptide response to increased endothelin-1 production in patients with chronic heart failure. European Heart Journal, , 502-502.
  • Doehner, W., Rauchhaus, M., Egerer, K., Banasiak, W., Coats, A., Anker, S., Piepoli, M., Ponikowski, P. (2001). Augmented peripheral chemosensitivity and periodic breathing pattern are related to elevated levels of the ob gen product leptin in patients with chronic heart failure. Journal of the American College of Cardiology, , 191A-191A.
  • Doehner, W., Piepoli, M., Coats, A., Anker, S., Ponikowski, P., Egerer, K. (2001). Augmented peripheral chemosensitivity and periodic breathing pattern in patients with chronic heart failure are related to elevated levels of the Ob gene product leptin. European Heart Journal, , 294-294.
  • Anker, S., Davos, C., Francis, D., Segal, R., Santoro, E., Poole-Wilson, P., Pitt, B., Coats, A. (2001). Body mass index, obesity, and cachexia vs survival in chronic heart failure: Results from the ELITE 2 study. Journal of the American College of Cardiology, , 203A-203A.
  • Coats, A. (2001). CAPRICORN: a story of alpha allocation and beta-blockers in left ventricular dysfunction post-MI. International Journal of Cardiology, 78, 109-113.
  • Scott, A., Francis, D., Davies, L., Kemp, M., Hooper, J., Coats, A., Piepoli, M. (2001). Chemical mediators of exaggerated muscle ergoreflex activity in chronic heart failure: role of prostaglandins and hydrogen ions in reflex ventilatory control. European Heart Journal, , 297-297.
  • Cicoira, M., Davos, C., Florea, V., Shamim, W., Doehner, W., Coats, A., Anker, S. (2001). Chronic heart failure in the very elderly: Clinical status, survival, and prognostic factors in 188 patients more than 70 years old. American Heart Journal, 142, 174-180.
  • Fox, K., Cowie, M., Wood, D., Coats, A., Gibbs, J., Underwood, S., Turner, R., Poole-Wilson, P., Davies, S., Sutton, G. (2001). Coronary artery disease as the cause of incident heart failure in the population. European Heart Journal, 22, 228-236.
  • Faris, R., Coats, A., Purcell, H., Henein, M. (2001). Depression is common and significantly associated with reduced survival in patients with dilated cardiomyopathy. European Heart Journal, , 414-414.
  • Francis, D., Davies, L., Coats, A. (2001). Diagnostic exercise physiology in chronic heart failure. Heart, 86, 17-20.
  • Al-Nasser, F., Doehner, W., Kaczmarek, A., Ponikowski, P., Piepoli, M., Coats, A., Henein, M. (2001). Echocardiographic derived variables predict intolerability to carvedilol in chronic heart failure. Journal of the American College of Cardiology, , 445A-445A.
  • Davies, L., Francis, D., Scott, A., Ponikowski, P., Piepoli, M., Coats, A. (2001). Effect of altering conditions of the sequence method on baroreflex sensitivity. Journal of Hypertension, 19, 1279-1287.
  • Tendera, M., Mohacsi, P., Krum, H., Fowler, M., Coats, A., Rouleau, J., Castaigne, A., Amann-Zalan, I., Staiger, C., Holcslaw, T., et al (2001). Effect of carvdilol on patients' well-being in severe chronic heart failure: Results of the COPERNICUS study. Circulation, , 719-719.
  • Carson, P., Fowler, M., Mohacsi, P., Krum, H., Tendera, M., Coats, A., Rouleau, J., Holcslaw, T., Staiger, C., Roecker, E., et al (2001). Effect of carvedilol in black patients with severe chronic heart failure: Results of the COPERNICUS study. Circulation, , 754-754.
  • Fowler, M., O'Connor, C., Carson, P., Tendera, M., Katus, H., Krum, H., Mohacsi, P., Coats, A., Rouleau, J., Roecker, E., et al (2001). Effect of carvedilol on frequency and severity of hospitalization in severe chronic heart failure: Results of the COPERNICUS study. Circulation, , 753-754.
  • Amann-Zalan, I., Tendera, M., Packer, M., Fowler, M., Katus, H., Krum, H., Mohacsi, P., Rouleau, J., Castaigne, A., Coats, A. (2001). Effect of carvedilol on global assessment of patients with severe chronic heart failure: the COPERNICUS study. European Heart Journal, , 299-299.
  • Amann-Zalan, I., Coats, A., Fowler, M., Katus, H., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Packer, M., Carson, P. (2001). Effect of carvedilol on hospitalization in patients with severe chronic heart failure: results of the COPERNICUS study. European Heart Journal, , 300-300.
  • Packer, M., Coats, A., Fowler, M., Katus, H., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Castaigne, A., Roecker, E., et al (2001). Effect of carvedilol on survival in severe chronic heart failure. New England Journal of Medicine, 344, 1651-1658.
  • Doehner, W., Rauchhaus, M., Leyva, F., Coats, A., Anker, S. (2001). Effect of xanthine oxidase inhibition with allopurinol on peripheral blood flow in CHF patients in a randomised, placebo-controlled, double-blind, cross-over study. European Heart Journal, , 403-403.
  • Al-Nasser, F., Bukachi, F., Yousufuddin, M., Henein, M., Ponikowski, P., Coats, A., Anker, S. (2001). Effects of carvedilol on left ventricular function: an echocardiographic follow-up study. European Heart Journal, , 298-298.
  • Yousufuddin, M., Flather, M., Wang, D., Yousef, Z., Marber, M., Parker, K., Wilson, K., Banner, N., Amrani, M., Coats, A. (2001). Effects of oral L-arginine supplement on peripheral vascular function in chronic heart failure a prospective, randomised, double-blind, placebo-controlled study. European Heart Journal, , 47-47.
  • Rauchhaus, M., Doehner, W., Bolger, A., Sharma, R., Schmidt, H., Davos, C., Kemp, M., Coats, A., Anker, S. (2001). Endotoxin and severity of chronic heart failure. Journal of the American College of Cardiology, , 190A-190A.
  • Ponikowski, P., Francis, D., Piepoli, M., Davies, L., Chua, T., Davos, C., Florea, V., Banasiak, W., Poole-Wilson, P., Coats, A., Anker, S. (2001). Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance - Marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation, 103, 967-972.
  • Piepoli, M., Wensel, R., Ponikowski, P., Francis, D., Davies, L., Capucci, A., Coats, A. (2001). Ergoreflex overactivation predicts reduced baroreflex sensitivity and autonomic abnormalities in chronic heart failure patients. European Heart Journal, , 548-548.
  • Bolger, A., Rashid, M., Sharma, R., Rauchhaus, M., Doehner, W., Stephens,, R., Barclay, R., Coats, A., Anker, S. (2001). Evidence of endotoxin exposure in patients with severe chronic heart failure by determination of antiendotoxin core antibody levels. Journal of the American College of Cardiology, , 190A-190A.
  • Coats, A. (2001). Exciting new drugs on the horizon - Eplerenone, a selective aldosterone receptor antagonist (SARA). International Journal of Cardiology, 80, 1-4.
  • Cicoira, M., Zanolla, L., Rossi, A., Golia, G., Franceschini, L., Cabrini, G., Bonizzato, A., Graziani, M., Anker, S., Coats, A., et al (2001). Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. Journal of the American College of Cardiology, 37, 1808-1812.
  • Cicoira, M., Bolger, A., Doehner, W., Rauchhaus, M., Davos, C., Sharma, R., Al-Nasser, F., Coats, A., Anker, S. (2001). High tumor necrosis factor levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. Journal of the American College of Cardiology, , 190A-190A.
  • Cicoira, M., Bolger, A., Doehner, W., Rauchhaus, M., Davos, C., Sharma, R., Al-Nasser, F., Coats, A., Anker, S. (2001). High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. Cytokine, 15, 80-86.
  • Doehner, W., Rauchhaus, M., Egerer, K., Strasburger, C., Pflaum, C., Davos, C., Coats, A., Anker, S. (2001). Hyperleptinaemia in chronic heart failure relates to growth hormone binding protein in male patients with and without cardiac cachexia. European Heart Journal, , 306-306.
  • Doehner, W., Rauchhaus, M., Egerer, K., Pflaum, C., Strasburger, C., Davos, C., Coats, A., Anker, S. (2001). Hyperleptinemia in chronic heart failure relates to growth hormone binding protein in male patients with and without cardiac cachexia. Journal of the American College of Cardiology, , 245A-245A.
  • Parissis, J., Adamopoulos, S., Karatzas, D., Kroupis, C., Karavolias, G., Paraskevaidis, J., Koniavitou, K., Karas, S., Kremastinos, D., Coats, A. (2001). Immunomodulatory effects of physical training in chronic heart failure. European Heart Journal, , 197-197.
  • Yousufuddin, M., Henein, M., Flather, M., Wang, D., Shamim, W., O'Sullivan, C., Kemp, M., Kazzam, E., Banner, N., Amrani, M., Coats, A. (2001). Incremental importance of peak-exercise plasma levels of endothelin-I and natriuretic peptides in chronic heart failure. Journal of Cardiovascular Pharmacology, 38, 468-473.
  • Hughes, P., Hart, N., Hamnegard, C., Green, M., Coats, A., Moxham, J., Polkey, M. (2001). Inspiratory muscle relaxation rate slows during exhaustive treadmill walking in patients with chronic heart failure. American Journal of Respiratory and Critical Care Medicine, 163, 1400-1403.
  • Doehner, W., Pflaum, C., Rauchhaus, M., Godsland, I., Egerer, K., Cicoira, M., Florea, V., Sharma, R., Bolger, A., Coats, A., Anker, S., et al (2001). Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. European Journal of Endocrinology, 145, 727-735.
  • Coats, A. (2001). Life, quality of life and choice in an ageing society. International Journal of Cardiology, 78, 1-3.
  • Scott, A., Ponikowski, P., Anker, S., Davos, C., Rauchhaus, M., Coats, A., Piepoli, M., Capucci, A. (2001). Limb lean tissue relates to exercise intolerance and muscle reflexes in chronic heart failure patients. European Heart Journal, , 405-405.
  • Coats, A. (2001). Making choices in cardiology: difficulties of rationing and equality of access. International Journal of Cardiology, 78, 209-212.
  • Coats, A. (2001). Medical malpractice, murder and the academic community: trouble ahead. International Journal of Cardiology, 79, 1-4.
  • Ponikowski, P., Chua, T., Francis, D., Capucci, A., Coats, A., Piepoli, M. (2001). Muscle Ergoreceptor Overactivity Reflects Deterioration in Clinical Status and Cardiorespiratory Reflex Control in Chronic Heart Failure. Circulation, 104, 2324-2330.
  • Scott, A., Capucci, A., Piepoli, M., Ponikowski, P., Anker, S., Davos, C., Rauchhaus, M., Coats, A. (2001). Muscle lean tissue reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. European Heart Journal, , 406-406.
  • Coats, A. (2001). Pericardial fluid - dispensable or indispensable fluid and an example of patentable bio-diversity. International Journal of Cardiology, 77, 109-111.
  • Ponikowski, P., Chua, T., Anker, S., Francis, D., Doehner, W., Banasiak, W., Poole-Wilson, P., Piepoli, M., Coats, A. (2001). Peripheral chemoreceptor hypersensitivity - An ominous sign in patients with chronic heart failure. Circulation, 104, 544-549.
  • Adamopoulos, S., Parissis, J., Kroupis, C., Georgiadis, M., Karatzas, D., Karavolias, G., Koniavitou, K., Coats, A., Kremastinos, D. (2001). Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. European Heart Journal, 22, 791-797.
  • Harrington, D., Anker, S., Coats, A. (2001). Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. European Heart Journal, 22, 392-399.
  • Coats, A., Anker, S., Roecker, E., Schultz, M., Staiger, C., Amann-Zalan, I., Shusterman, N., Packer, M. (2001). Prevention and reversal of cardiac cachexia in patients with severe heart failure by carvedilol: Results of the COPERNICUS study. Circulation, , 437-437.
  • Shamim, W., Yousufuddin, M., Francis, D., Gualdiero, P., Honour, J., Anker, S., Coats, A. (2001). Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: possible evidence for partial glucocorticoid resistance. Heart, 86, 139-144.
  • Davies, L., Francis, D., Ponikowski, P., Piepoli, M., Coats, A. (2001). Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. The American Journal of Cardiology, 87, 737-742.
  • Scott, A., Davies, L., Francis, D., Coats, A., Piepoli, M. (2001). Role of skeletal muscle afferents in the respiratory control in chronic heart failure. European Heart Journal, , 405-405.
  • Krum, H., Coats, A., Fowler, M., Mohacsi, P., Rouleau, J., Tendera, M., Roecker, E., Amann-Zalan, I., Staiger, C., Holcslaw, T., et al (2001). Safety and tolerability of carvedilol in patients with severe chronic heart failure: Results of the COPERNICUS study. Circulation, , 717-717.
  • Rauchhaus, M., Doehner, W., Davos, C., Sharma, R., Bolger, A., Gabriel, H., Kemp, M., Coats, A., Anker, S. (2001). Serum total cholesterol, high-density lipoprotein, and prognosis in patients with chronic heart failure. Journal of the American College of Cardiology, , 156A-156A.
  • Mohacsi, P., Fowler, M., Krum, H., Tendera, M., Coats, A., Rouleau, J., Amann-Zalan, I., Holcslaw, T., Roecker, E., Packer, M. (2001). Should physicians avoid the use of beta-blockers in patients with heart failure who have diabetes? Results of the COPERNICUS study. Circulation, , 754-754.
  • Davos, C., Francis, D., Segal, R., Poole-Wilson, P., Pitt, P., Coats, A., Anker, S. (2001). Survival in chronic heart failure in the ELITE-2 study: the importance of body weight, weight loss and uric acid. European Heart Journal, , 265.
  • Coats, A. (2001). The effects of angiotensin receptor antagonists on mortality and morbidity in heart failure - and an interaction with beta blockade. International Journal of Cardiology, 77, 1-4.
  • Scott, A., Davies, L., Capucci, A., Coats, A., Piepoli, M. (2001). The relationship between skeletal muscle metaboreceptors in the upper and lower limbs and the respiratory control in heart failure. European Heart Journal, , 297-297.
  • Kalra, P., Anker, S., Struthers, A., Coats, A. (2001). The role of C-type natriuretic peptide in cardiovascular medicine. European Heart Journal, 22, 997-1007.
  • Henein, M., O'Sullivan, C., Coats, A., Gibson, D., Sheppard, M. (2001). TOE with 3D reconstruction reveals organic tricuspid valve disease in patients with severe valve regurgitation and apparently normal cusp morphology. Journal of Pathology, , 41A-41A.
  • Doehner, W., Rauchhaus, M., Florea, V., Sharma, R., Bolger, A., Davos, C., Coats, A., Anker, S. (2001). Uric acid in cachectic and noncachectic patients with chronic heart failure: Relationship to leg vascular resistance. American Heart Journal, 141, 792-799.
  • Scott, A., Francis, D., Davies, L., Coats, A., Piepoli, M. (2001). Validation of a treadmill exercise test protocol with improved metabolic plateau formation in patients with chronic congestive heart failure. The American Journal of Cardiology, 87, 1328-1331.
  • Sharma, R., Florea, V., Bolger, A., Doehner, W., Florea, N., Coats, A., Hodson, M., Anker, S., Henein, M. (2001). Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax, 56, 746-750.
  • Florea, V., Moon, J., Pennell, D., Doehner, W., Coats, A., Anker, S. (2001). Wasting of the left ventricle in patients with cardiac cachexia: A prospective cardiovascular magnetic resonance study. Circulation, , 168-168.
  • Kalra, P., Anker, S., Coats, A. (2001). Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin. Cardiovascular Research, 51, 495-509.
  • Coats, A. (2001). What causes the symptoms of heart failure? Heart, 86, 574-578.
  • Doehner, W., Coats, A., Anker, S. (2001). Xanthine oxidase inhibition with allopurinol improves peripheral blood flow in hyperuricaemic CHF patients in a placebo controlled, double blind, cross-over treatment study. Circulation, , 437-437.

2011

  • Manzano, L., Babalis, D., Roughton, M., Shibata, M., Anker, S., Ghio, S., van Veldhuisen, D., Cohen-Solal, A., Coats, A., Poole-Wilson, P., et al (2011). Predictors of clinical outcomes in elderly patients with heart failure. European Journal of Heart Failure, 13(5), 528-536. [More Information]
  • Coats, A., Shewan, L. (2011). Statement on authorship and publishing ethics in the international journal of cardiology. International Journal of Cardiology, 153(3), 239-240. [More Information]
  • Ambrosio, G., Flather, M., Bohm, M., Cohen-Solal, A., Murrone, A., Mascagni, F., Spinucci, G., Conti, M., Van Veldhuisen, D., Tavazzi, L., Coats, A. (2011). β-blockade with nebivolol for prevention of acute ischaemic events in elderly patients with heart failure. E-Heart, 97(3), 209-214. [More Information]

2010

  • Kalra, P., Clague, J., Coats, A., Anker, S., Poole-Wilson, P., Struthers, A. (2010). C-type Natriuretic Peptide Production by the Human Kidney is Blunted in Chronic Heart Failure. Clinical Science, 118, 71-77. [More Information]
  • Shewan, L., Coats, A. (2010). Ethics in the authorship and publishing of scientific articles. International Journal of Cardiology, 144(1), 1-2. [More Information]
  • Davies, E., Moxham, T., Rees, K., Singh, S., Coats, A., Ebrahim, S., Lough, F., Taylor, R. (2010). Exercise Training for Systolic Heart Failure: Cochrane Systematic Review and Meta-Analysis. European Journal of Heart Failure, 12(7), 706-715. [More Information]
  • Ng, A., Davis, G., Chow, C., Coats, A., Sindone, A., Freedman, B. (2010). Impact of sleep disordered breathing severity on hemodynamics, autonomic balance and cardiopulmonary functional status in chronic heart failure. International Journal of Cardiology, 141(3), 227-235. [More Information]
  • de Boer, R., Doehner, W., van der Horst, I., Anker, S., Babalis, D., Roughton, M., Coats, A., Flather, M., van Veldhuisen, D. (2010). Influence of Diabetes Mellitus and Hyperglycemia on Prognosis in Patients >70 Years Old With Heart Failure and Effects of Nebivolol (Data from the Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure [SENIORS]). The American Journal of Cardiology, 106(1), 78-86.e1. [More Information]
  • Barron, A., Medlow, K., Giannoni, A., Unsworth, B., Coats, A., Mayet, J., Howard, L., Francis, D. (2010). Reduced Confounding by Impaired Ventilatory Function With Oxygen Uptake Efficiency Slope and VE/VCO(2) Slope Rather Than Peak Oxygen Consumption to Assess Exercise Physiology in Suspected Heart Failure. Congestive Heart Failure, 16(6), 259-264. [More Information]
  • Coats, A. (2010). Retraction of a paper containing plagiarized material: The prognostic value of serum troponin T in unstable angina. G??khan Cin V, G??k H, Kaptano??lu B. Int J Cardiol. 1996 Mar;53(3):237-44. International Journal of Cardiology, 145(3), e81-2. [More Information]

2009

  • van Veldhuisen, D., Cohen-Solal, A., Bohm, M., Anker, S., Babalis, D., Roughton, M., Coats, A., Poole-Wilson, P., Flather, M. (2009). Beta-Blockade With Nebivolol in Elderly Heart Failure Patients With Impaired and Preserved Left Ventricular Ejection Fraction Data From SENIORS (Study of Effects of Nebivolol Intervention on Outcomes and Rehospitalization in Seniors With Heart Failure). Journal of the American College of Cardiology, 53(23), 2150-2158. [More Information]
  • Cohen-Solal, A., Kotecha, D., van Veldhuisen, D., Babalis, D., Bohm, M., Coats, A., Roughton, M., Poole-Wilson, P., Tavazzi, L., Flather, M. (2009). Efficacy and safety of nebivolol in elderly heart failure patients with impaired renal function: insights from the SENIORS trial. European Journal of Heart Failure, 11(9), 872-880. [More Information]

2008

  • Coats, A. (2008). Ethical authorship and publishing. International Journal of Cardiology, 131(2), 149-50. [More Information]
  • Yao, G., Freemantle, N., Flather, M., Tharmanathan, P., Coats, A., Poole-Wilson, P. (2008). Long-Term Cost-Effectiveness Analysis of Nebivolol Compared with Standard Care in Elderly Patients with Heart Failure An Individual Patient-Based Simulation Model. PharmacoEconomics, 26(10), 879-889. [More Information]
  • Coats, A. (2008). Retraction of “Xue SR. Xue Y. Xue R. Carvedilol restore cardiac calcium release channel structure and function in heart failure. Int. J Cardiology. 116(2):231-5, 2007�? containing plagiarised material. International Journal of Cardiology, 125(3), 293-293. [More Information]
  • Coats, A., Williamson, E. (2008). Scientific deception: Retraction of a fraudulent paper. International Journal of Cardiology, 131, 297. [More Information]
  • Coats, A. (2008). The top papers by download and citations from the International Journal of Cardiology in 2007. International Journal of Cardiology, 131(1), e1-3. [More Information]

2007

  • Ponikowski, P., Anker, S., Szachniewicz, J., Okonko, D., Ledwidge, M., Zymlinski, R., Ryan, E., Wasserman, S., Baker, N., Coats, A., et al (2007). Effect of darbepoetin alfa on exercise tolerance in anemic patients with symptomatic chronic heart failure: a randomized, double-blind, placebo-controlled trial. Journal of the American College of Cardiology, 49(7), 753-762. [More Information]
  • Clark, A., Knosalla, C., Birks, E., Loebe, M., Davos, C., Tsang, S., Negassa, A., Yacoub, M., Hetzer, R., Coats, A., et al (2007). Heart transplantation in heart failure: the prognostic importance of body mass index at time of surgery and subsequent weight changes. European Journal of Heart Failure, 9(8), 839-844. [More Information]
  • Piepoli, M., Coats, A. (2007). Increased metaboreceptor stimulation explains the exaggerated exercise pressor reflex seen in heart failure. Journal of Applied Physiology, 102(1), 494-497. [More Information]
  • Dobre, D., van Veldhuisen, D., Mordenti, G., Vintila, M., Haaijer-Ruskamp, F., Coats, A., Poole-Wilson, P., Flather, M. (2007). Tolerability and dose-related effects of nebivolol in elderly patients with heart failure: data from the Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS) trial. American Heart Journal, 154(1), 109-115. [More Information]

2006

  • Szollosi, I., O'driscoll, D., Dayer, M., Coats, A., Morrell, M., Simonds, A. (2006). Adaptive servo-ventilation and deadspace: effects on central sleep apnoea. Journal of Sleep Research, 15(2), 199-205. [More Information]
  • Krum, H., Mohacsi, P., Katus, H., Tendera, M., Rouleau, J., Fowler, M., Coats, A., Roecker, E., Packer, M., Carvedilol, S. (2006). Are beta-blockers needed in patients receiving spironolactone for severe chronic heart failure? An analysis of the COPERNICUS study. American Heart Journal, 151(1), 55-61. [More Information]
  • Coats, A. (2006). Beta-adrenoceptor antagonists in elderly patients with chronic heart failure: therapeutic potential of third-generation agents. Drugs and Aging, 23(2), 93-99. [More Information]
  • Dawes, M., Coats, A., Juszczak, E. (2006). Daytime ambulatory systolic blood pressure is more effective at predicting mortality than clinic blood pressure. Blood pressure monitoring, 11(3), 111-118. [More Information]
  • Faris, R., Flather, M., Purcell, H., Poole-Wilson, P., Coats, A. (2006). Diuretics for heart failure. Cochrane Database of Systematic Reviews, 1(1), 3838-3838. [More Information]
  • Davies, L., Wensel, R., Georgiadou, P., Cicoira, M., Coats, A., Piepoli, M., Francis, D. (2006). Enhanced prognostic value from cardiopulmonary exercise testing in chronic heart failure by non-linear analysis: oxygen uptake efficiency slope. European Heart Journal, 27(6), 684-690. [More Information]
  • Thomas, M., Fox, K., Coats, A. (2006). Redefining heart failure. International Journal of Cardiology, 112(2), 139-141. [More Information]
  • Rao, A., Georgiadou, P., Francis, D., Johnson, A., Kremastinos, D., Simonds, A., Coats, A., Cowley, A., Morrell, M. (2006). Sleep-disordered breathing in a general heart failure population: relationships to neurohumoral activation and subjective symptoms. Journal of Sleep Research, 15(1), 81-88. [More Information]
  • Anker, S., Clark, A., Winkler, R., Zugck, C., Cicoira, M., Ponikowski, P., Davos, C., Banasiak, W., Zardini, P., Haass, M., Coats, A., et al (2006). Statin use and survival in patients with chronic heart failure - results from two observational studies with 5200 patients. International Journal of Cardiology, 112(2), 234-242. [More Information]
  • Genth-Zotz, S., von Haehling, S., Bolger, A., Kalra, P., Wensel, R., Coats, A., Volk, H., Anker, S. (2006). The anti-CD14 antibody IC14 suppresses ex vivo endotoxin stimulated tumor necrosis factor-alpha in patients with chronic heart failure. European Journal of Heart Failure, 8(4), 366-372. [More Information]
  • McLean, A., Eslick, G., Coats, A. (2006). The epidemiology of heart failure in Australia. International Journal of Cardiology, 118(3), 370-374. [More Information]
  • Shewan, L., Coats, A. (2006). The Research Quality Framework and its implications for health and medical research: time to take stock? Medical Journal of Australia, 184(9), 463-466. [More Information]

2005

  • Coats, A. (2005). Advances in the non-drug, non-surgical, non-device management of chronic heart failure. International Journal of Cardiology, 100(1), 1-4. [More Information]
  • Okonko, D., Crosato, M., Kalra, P., Cicoira, M., John, M., Doehner, W., Coats, A., Poole-Wilson, P., Anker, S. (2005). Association of deranged adrenal steroid metabolism with anemia in chronic heart failure. The American Journal of Cardiology, 96(1), 101-103. [More Information]
  • Stewart, S., McMurray, J., Hebborn, A., Coats, A., Packer, M. (2005). Carvedilol reduces the costs of medical care in severe heart failure: an economic analysis of the COPERNICUS study applied to the United Kingdom. International Journal of Cardiology, 100(1), 143-149. [More Information]
  • Sharma, R., Bolger, A., Rauchhaus, M., von Haehling, S., Doehner, W., Adcock, I., Barnes, P., Poole-Wilson, P., Volk, H., Coats, A., et al (2005). Cellular endotoxin desensitization in patients with severe chronic heart failure. European Journal of Heart Failure, 7(5), 865-868. [More Information]
  • Rossi, A., Cicoira, M., Florea, V., Golia, G., Florea, N., Khan, A., Murray, S., Nguyen, J., O'Callaghan, P., Coats, A., et al (2005). Chronic heart failure with preserved left ventricular ejection fraction: Diagnostic and prognostic value of left atrial size. International Journal of Cardiology, 110(3), 386-392. [More Information]
  • Shewan, L., Glatz, J., Bennett, C., Coats, A. (2005). Contemporary (post-Wills) survey of the views of Australian medical researchers: importance of funding, infrastructure and motivators for a research career. Medical Journal of Australia, 183(11/12), 606-611. [More Information]
  • Coats, A. (2005). Dyspnoea in CHF and COPD. International Journal of Cardiology, 105(3), 351-351. [More Information]
  • Thomas, M., Fox, K., Wood, D., Gibbs, J., Coats, A., Henein, M., Poole-Wilson, P., Sutton, G. (2005). Echocardiographic features and brain natriuretic peptides in patients presenting with heart failure and preserved systolic function. Heart, 92(5), 603-608. [More Information]
  • Wensel, R., Francis, D., Georgiadou, P., Scott, A., Genth-Zotz, S., Anker, S., Coats, A., Piepoli, M. (2005). Exercise hyperventilation in chronic heart failure is not caused by systemic lactic acidosis. European Journal of Heart Failure, 7(7), 1105-1111. [More Information]
  • Niebauer, J., Clark, A., Webb-Peploe, K., Coats, A. (2005). Exercise training in chronic heart failure: effects on pro-inflammatory markers. European Journal of Heart Failure, 7(2), 189-193. [More Information]
  • Coats, A. (2005). Five years of progress for international journal of cardiology. International Journal of Cardiology, 100(1), 173-175. [More Information]
  • Niebauer, J., Clark, A., Webb-Peploe, K., Böger, R., Coats, A. (2005). Home-based exercise training modulates pro-oxidant substrates in patients with chronic heart failure. European Journal of Heart Failure, 7(2), 183-188. [More Information]
  • Doehner, W., Rauchhaus, M., Ponikowski, P., Godsland, I., von Haehling, S., Okonko, D., Leyva, F., Proudler, A., Coats, A., Anker, S. (2005). Impaired insulin sensitivity as an independent risk factor for mortality in patients with stable chronic heart failure. Journal of the American College of Cardiology, 46(6), 1019-1026. [More Information]
  • Kalantar-Zadeh, K., Anker, S., Coats, A., Horwich, T., Fonarow, G. (2005). Obesity paradox as a component of reverse epidemiology in heart failure. Archives of Internal Medicine, 165(15), 1797; author reply 1797-8. [More Information]
  • Edmonds, P., Rogers, A., Addington-Hall, J., McCoy, A., Coats, A., Gibbs, J. (2005). Patient descriptions of breathlessness in heart failure. International Journal of Cardiology, 98(1), 61-66. [More Information]
  • Flather, M., Shibata, M., Coats, A., Van Veldhuisen, D., Parkhomenko, A., Borbola, J., Cohen-Solal, A., Dumitrascu, D., Ferrari, R., Lechat, P., et al (2005). Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS). European Heart Journal, 26(3), 215-225. [More Information]
  • Kalantar-Zadeh, K., Anker, S., Coats, A., Horwich, T., Fonarow, G. (2005). Reply: Obesity paradox as a component of reverse epidemiology in heart failure. Archives of Internal Medicine, , 1797-1798.
  • Sharma, R., Tigas, S., Rauchhaus, M., Poole-Wilson, P., Coats, A., Umpleby, M., Carroll, A., Anker, S. (2005). Substrate metabolism in patients with chronic heart failure with and without cachexia. Circulation, 112, U660-U660.
  • Coats, A. (2005). Top of the charts: download versus citations in the International Journal of Cardiology. International Journal of Cardiology, 105(2), 123-125. [More Information]
  • Sharma, R., von Haehling, S., Rauchhaus, M., Bolger, A., Genth-Zotz, S., Doehner, W., Oliver, B., Poole-Wilson, P., Hans-Dieter, V., Coats, A., et al (2005). Whole blood endotoxin responsiveness in patients with chronic heart failure: the importance of serum lipoproteins. European Journal of Heart Failure, 7(4), 479-484. [More Information]
  • Coats, A. (2005). Why ventilatory inefficiency matters in chronic heart failure. European Heart Journal, 26(5), 426-427. [More Information]

2004

  • Coats, A. (2004). Anaemia and heart failure. Heart, 90, 977-979.
  • Onwuamaegbu, M., Henein, M., Coats, A. (2004). Cachexia In Malaria And Heart Failure: Therapeutic Considerations In Clinical Practice. Postgraduate Medical Journal, 80(949), 642-649.
  • Kerr, J., Cunniffe, V., Kelleher, P., Coats, A., Mattey, D. (2004). Circulating Cytokines And Chemokines In Acute Symptomatic Parvovirus B19 Infection: Negative Association Between Levels Of Pro-Inflammatory Cytokines And Development Of B19-Associated Arthritis. Journal of Medical Virology, 74(1), 147-155. [More Information]
  • Wensel, R., Georgiadou, P., Francis, D., Bayne, S., Scott, A., Genth-Zotz, S., Anker, S., Coats, A., Piepoli, M. (2004). Differential Contribution Of Dead space Ventilation And Low Arterial Pco2 To Exercise Hyperpnea In Patients With Chronic Heart Failure Secondary To Ischemic Or Idiopathic Dilated Cardiomyopathy. The American Journal of Cardiology, 93(3), 318-323. [More Information]
  • Szollosia, I., Jones, M., Morrell, M., Helfetb, K., Coats, A., Simonds, A. (2004). Effect Of Co₂ Inhalation On Central Sleep Apnea And Arousals From Sleep. Respiration, 71(5), 493-498.
  • Bellenger, N., Rajappan, K., Rahman, S., Lahiri, A., Raval, U., Webster, J., Murray, G., Coats, A., Cleland, J., Pennell, D. (2004). Effects Of Carvedilol On Left Ventricular Remodelling In Chronic Stable Heart Failure: A Cardiovascular Magnetic Resonance Study. Heart, 90(7), 760-764.
  • Rees, K., Taylor, R., Singh, S., Coats, A., Ebrahim, S. (2004). Exercise Based Rehabilitation For Heart Failure. Cochrane Database of Systematic Reviews, 2004 (3), CD003331.
  • Piepoli, M., Davos, C., Francis, D., Coats, A. (2004). Exercise Training Meta-Analysis Of Trials In Patients With Chronic Heart Failure (Extramatch). BMJ: British Medical Journal, 328(7433), 189-195.
  • Sharma, R., Francis, D., Pitt, B., Poole-Wilson, P., Coats, A., Anker, S. (2004). Haemoglobin Predicts Survival In Patients With Chronic Heart Failure: A Substudy Of The Elite Ii Trial. European Heart Journal, 25(12), 1021-1028. [More Information]
  • Genth-Zotz, S., Bolger, A., Kalra, P., von Haehling, S., Doehner, W., Coats, A., Volk, H., Anker, S. (2004). Heat Shock Protein 70 In Patients With Chronic Heart Failure: Relation To Disease Severity And Survival. International Journal of Cardiology, 96(3), 397-401. [More Information]
  • Rouleau, J., Roecker, E., Tendera, M., Mohacsi, P., Krum, H., Katus, H., Fowler, M., Coats, A., Castaigne, A., Scherhag, A., et al (2004). Influence Of Pretreatment Systolic Blood Pressure On The Effect Of Carvedilol In Patients With Severe Chronic Heart Failure: The Carvedilol Prospective Randomized Cumulative Survival (Copernicus) Study. Journal of the American College of Cardiology, 43(8), 1423-1429. [More Information]
  • Collinson, J., Flather, M., Coats, A., Pepper, J., Henein, M. (2004). Influence Of Valve Prosthesis Type On The Recovery Of Ventricular Dysfunction And Subendocardial Ischaemia Following Valve Replacement For Aortic Stenosis. International Journal of Cardiology, 97(3), 535-541.
  • Rosen, S., Murphy, K., Leff, A., Cunningham, V., Wise, R., Adams, L., Coats, A., Camici, P. (2004). Is Central Nervous System Processing Altered In Patients With Heart Failure? European Heart Journal, 25(11), 952-962. [More Information]
  • Salukhe, T., Dimopoulos, K., Sutton, R., Coats, A., Piepoli, M., Francis, D. (2004). Life-Years Gained From Defibrillator Implantation: Markedly Nonlinear Increase During 3 Years Of Follow-Up And Its Implications. Circulation, 109(15), 1848-1853.
  • Dimopoulos, K., Salukhe, T., Coats, A., Piepoli, M., Mayet, J., Francis, D. (2004). Meta-Analyses Of Mortality And Morbidity Effects Of An Angiotensin Receptor Blocker In Patients With Chronic Heart Failure Already Receiving An Ace Inhibitor (Alone Or With A Beta-Blocker). International Journal of Cardiology, 93(2-3), 105-111. [More Information]
  • Hartmann, F., Packer, M., Coats, A., Fowler, M., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Castaigne, A., Trawinski, J., et al (2004). Nt-Probnp In Severe Chronic Heart Failure: Rationale, Design And Preliminary Results Of The Copernicus Nt-Probnp Substudy. European Journal of Heart Failure, 6(3), 343-350. [More Information]
  • Cicoira, M., Davos, C., Francis, D., Doehner, W., Zanolla, L., Franceschini, L., Piepoli, M., Zardini, P., Coats, A., Poole-Wilson, P., et al (2004). Prediction Of Mortality In Chronic Heart Failure From Peak Oxygen Consumption Adjusted For Either Body Weight Or Lean Tissue. Journal of Cardiac Failure, 10(5), 421-426. [More Information]
  • Hartmann, F., Packer, M., Coats, A., Fowler, M., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Castaigne, A., et, A. (2004). Prognostic Impact Of Plasma N-Terminal Pro-Brain Natriuretic Peptide In Severe Chronic Congestive Heart Failure: A Substudy Of The Carvedilol Prospective Randomized Cumulative Survival (Copernicus) Trial. Circulation, 110(13), 1780-1786.
  • Scott, A., Wensel, R., Davos, C., Georgiadou, P., Davies, L., Coats, A., Francis, D., Piepoli, M. (2004). Putative Contribution Of Prostaglandin And Bradykinin To Muscle Reflex Hyperactivity In Patients On Ace-Inhibitor Therapy For Chronic Heart Failure. European Heart Journal, 25(20), 1806-1813. [More Information]
  • Thomas, M., Fox, K., Coats, A., Sutton, G. (2004). The Epidemiological Enigma Of Heart Failure With Preserved Systolic Function. European Journal of Heart Failure, 6(2), 125-136. [More Information]
  • Florea, V., Moon, J., Pennell, D., Doehner, W., Coats, A., Anker, S. (2004). Wasting Of The Left Ventricle In Patients With Cardiac Cachexia: A Cardiovascular Magnetic Resonance Study. International Journal of Cardiology, 97(1), 15-20. [More Information]

2003

  • Coats, A. (2003). Adult congenital heart disease in the international journal of cardiology. International Journal of Cardiology, 11, 125-126.
  • Scott, A., Roe, N., Coats, A., Piepoli, M. (2003). Aerobic exercise physiology in a professional rugby union team. International Journal of Cardiology, 87(2-3), 173-177.
  • Davos, C., Doehner, W., Rauchhaus, M., Cicoira, M., Francis, D., Coats, A., Clark, A., Anker, S. (2003). Body mass and survival in patients with chronic heart failure without cachexia: the importance of obesity. Journal of Cardiac Failure, 9(1), 29-35.
  • Bolger, A., Coats, A., Gatzoulis, M. (2003). Congenital heart disease: the original heart failure syndrome. European Heart Journal, 24(10), 970-976.
  • McCrohon, J., Moon, J., Prasad, S., McKenna, W., Lorenz, C., Coats, A., Pennell, D. (2003). Differentiation of heart failure related to dilated cardiomyopathy and coronary artery disease using gadolinium-enhanced cardiovascular magnetic resonance. Circulation, 108, 54-59.
  • Kalra, P., Bolger, A., Francis, D., Genth-Zotz, S., Sharma, R., Ponikowski, P., Poole-Wilson, P., Coats, A., Anker, S. (2003). Effect of anemia on exercise tolerance in chronic heart failure in men. The American Journal of Cardiology, 91, 888-891.
  • Al-Nasser, F., Yousufuddin, M., Al-Nozha, F., Anker, S., Coats, A., Piepoli, M., Ponikowski, P. (2003). Effect of carvedilol on exercise tolerance in patients with chronic heart failure and a restrictive left ventricular filling pattern. The American Journal of Cardiology, 91(10), 1281-1283.
  • Krum, H., Roecker, E., Mohacsi, P., Rouleau, J., Tendera, M., Coats, A., Katus, H., Fowler, M., Packer, M. (2003). Effects of Initiating Carvedilol in Patients With Severe Chronic Heart Failure. JAMA: The Journal of the American Medical Association, 289(6 (reprinted)), 712-718. [More Information]
  • Sharma, R., Bolger, A., Li, W., Davlouros, P., Volk, H., Poole-Wilson, P., Coats, A., Gatzoulis, M., Anker, S. (2003). Elevated circulating levels of inflammatory cytokines and bacterial endotoxin in adults with congential heart disease. The American Journal of Cardiology, 92(2), 188-193.
  • Davos, C., Francis, D., Leenarts, M., Yap, S., Li, W., Davlouros, P., Wensel, R., Coats, A., Piepoli, M., Sreeram, N., et al (2003). Global impairment of cardiac autonomic nervous activity late after the fontan operation. Circulation, 108(supp II), II-180-II-185.
  • Kalra, P., Collier, T., Cowie, M., Fox, K., Wood, D., Poole-Wilson, P., Coats, A., Sutton, G. (2003). Haemoglobin concentration and prognosis in new cases of heart failure. The Lancet, 362(9379), 211-212.
  • Crisafulli, A., Scott, A., Wensel, R., Davos, C., Francis, D., Pagliaro, P., Coats, A., Concu, A., Piepoli, M. (2003). Muscle metaboreflex-induced increases in stroke volume. Medicine and Science in Sports and Exercise, 35(2), 221-228.
  • Kalra, P., Clague, J., Bolger, A., Anker, S., Poole-Wilson, P., Struthers, A., Coats, A. (2003). Myocardial production of C-type natriuretic peptide in chronic heart failure. Circulation, 107(4), 571-573.
  • Cleland, J., Pennell, D., Coats, A., Ray, S., Macfarlane, P., Murray, G., Dalle Mule, J., Vered, Z., Lahiri, A. (2003). Myocardial viability as a determinant of the ejection fraction response to carvedilol in patients with heart failure( CHRISTMAS trial): randomized controlled trial. The Lancet, 362(9377), 14-21.
  • Anker, S., Negassa, A., Coats, A., Afzal, R., Poole-Wilson, P., Cohn, J., Yusuf, S. (2003). Prognostic importance of weight loss in chronic heart failure and the effect of treatment with angiotensin-converting-enzyme inhibitors: an observational study. The Lancet, 361(9363), 1077-1083.
  • Russell, S., Selaru, P., Pyne, D., Ghazzi, M., Massey, K., Pressler, M., Serikoff, A., Coats, A. (2003). Rationale for use of an exercise end point and design for the ADVANCE (A Dose evaluation of a Vasopressin ANtagonist in CHF patients undergoing Excerise) trial. American Heart Journal, 145(1), 179-186.
  • Scott, A., Francis, D., Coats, A., Piepoli, M. (2003). Reproducibility of the measurement of the muscle ergoreflex activity in chronic heart failure. European Journal of Heart Failure, 5(4), 453-461.
  • Williams, S., Wright, D., Marshall, P., Reese, A., Tzeng, B., Coats, A., Tan, L. (2003). Safety and potential benefits of low dose diamorphine during exercise in patients with chronic heart failure. Heart, 89(9), 1085-1086.
  • Scott, A., Wensel, R., Davos, C., Georgiadou, P., Kemp, M., Hooper, J., Coats, A., Piepoli, M. (2003). Skeletal muscle reflex in heart failure patients: Role of hydrogen. Circulation, 107, 300-306.
  • von Haehling, S., Genth-Zotz, S., Sharma, R., Bolger, A., Doehner, W., Barnes, P., Coats, A., Anker, S. (2003). The relationship between age and production of tumour necrosis factor- alpha in healthy volunteers and patients with chronic heart failure. International Journal of Cardiology, 90(2-3), 197-204.
  • Rauchhaus, M., Clark, A., Doehner, W., Davos, C., Bolger, A., Sharma, R., Coats, A., Anker, S. (2003). The relationship between cholesterol and survival in patients with chronic heart failure. Journal of the American College of Cardiology, 42(11), 1933-1940. [More Information]
  • Anker, S., Doehner, W., Rauchhaus, M., Sharma, R., Francis, D., Knosalla, C., Davos, C., Cicoira, M., Shamim, W., Kemp, M., Coats, A., et al (2003). Uric acid and survival in chronic heart failure: Validation and application in metabolic, functional and hemodynamic staging. Circulation, 107, 1991-1997.
  • Coats, A. (2003). Use of carvedilol in the treatment of heart failure. British Journal of Hospital Medicine, 64(5), 288-291.
  • Halamek, J., Kara, T., Jurak, P., Soucek, M., Francis, D., Davies, L., Shen, W., Coats, A., Novak, M., Novakova, Z., et al (2003). Variability of phase shift between blood pressure and heart rate fluctuations. A marker of short-term circulation control. Circulation, 108, 292-297.
  • Faris, R., Henein, M., Coats, A. (2003). Ventricular long axis function is predictive of outcome in patients with chronic heart failure secondary to non-ischemic dilated cardiomyopathy. Medical Science Monitor, 9(11), 456-465.

2002

  • Davies, L., Colhoun, H., Coats, A., Piepoli, M., Francis, D. (2002). A noninvasive measure of baroreflex sensitivity without blood pressure measurement. American Heart Journal, 143(3), 441-447.
  • Rogers, A., Addington-Hall, J., McCoy, A., Edmonds, P., Abery, A., Coats, A., Gibbs, J. (2002). A qualitative study of chronic heart failure patients' understanding of their symptoms and drug therapy. European Journal of Heart Failure, 4(3), 283-287.
  • Davies, L., Francis, D., Wilson, K., Scott, A., Piepoli, M., Coats, A. (2002). Abnormal temporal dynamics of blood pressure and RR interval regulation in patients with chronic heart failure: relationship to baroreflex sensitivity. International Journal of Cardiology, 86(1), 107-114.
  • Coats, A. (2002). Angiotensin type-1 receptor blockers in heart failure. Progress In Cardiovascular Diseases, 44(4), 231-242.
  • Al-Nasser, F., Duncan, A., Sharma, R., O'Sullivan, C., Coats, A., Anker, S., Henein, M. (2002). Beta-blocker therapy for dynamic left-ventricular outflow tract obstruction. International Journal of Cardiology, 86(2-3), 199-205.
  • Scott, A., Davos, C., Wensel, R., Kemp, M., Kaczmarek, A., Hooper, J., Coats, A., Piepoli, M. (2002). Chemical mediators of the muscle ergoreflex in chronic heart failure - A putative role for prostaglandins in reflex ventilatory control. Circulation, 106(2), 214-220.
  • Kalra, P., Sharma, R., Shamim, W., Doehner, W., Wensel, R., Bolger, A., Genth-Zotz, S., Cicoira, M., Coats, A., Anker, S. (2002). Clinical characteristics and survival of patients with chronic heart failure and prolonged QRS duration. International Journal of Cardiology, 86(2-3), 225-231.
  • Faris, R., Purcell, H., Henein, M., Coats, A. (2002). Clinical depression is common and significantly associated with reduced survival in patients with non-ischaemic heart failure. European Journal of Heart Failure, 4, 541-551.
  • Faris, R., Flather, M., Purcell, H., Henein, M., Poole-Wilson, P., Coats, A. (2002). Current evidence supporting the role of diuretics in heart failure: a meta analysis of randomised controlled trials. International Journal of Cardiology, 82(2), 149-158.
  • Moon, J., Kalra, P., Coats, A. (2002). DANAMI-2: Is primary angioplasty superior to thrombolysis in acute MI when the patient has to be transferred to an invasive centre? International Journal of Cardiology, 85(2-3), 199-201.
  • Kalra, P., Moon, J., Coats, A. (2002). Do results of the ENABLE (Endothelin Antagonist Bosentan for Lowering Cardiac Events in Heart Failure) study spell the end for non-selective endothelin antagonism in heart failure? International Journal of Cardiology, 85(2-3), 195-197.
  • Miller, A., O'Connor, C., Coats, A., Krum, H., Tendera, M., Mohasci, P., Rouleau, J., Fowler, M., Katus, H., Roecker, E., et al (2002). Does digitalis influence the response to beta-blockade in patients with severe chronic heart failure? Results of the COPERNICUS study. Journal of the American College of Cardiology, 39(Supplement 1), 166A-166A.
  • Mohacsi, P., Krum, H., Rouleau, J., Fowler, M., Katus, H., Coats, A., Tendera, M., Amann-Zalan, I., Roecker, E., Packer, M. (2002). Does the degree of interference with the renin-angiotensin system influence the response to B-blockade in chronic heart failure? Results of the COPERNICUS study. Journal of the American College of Cardiology, 39(Supplement 1), 167A-167A.
  • Faris, R., Coats, A., Henein, M. (2002). Echocardiography-derived variables predict outcome in patients with nonischemic dilated cardiomyopathy with or without a restrictive filling pattern. American Heart Journal, 144(2), 343-350.
  • Packer, M., Fowler, M., Roecker, E., Coats, A., Katus, H., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Staiger, C., et al (2002). Effect of carvedilol on the morbidity of patients with severe chronic heart failure - Results of the Carvedilol Prospective Randomized Cumulative Survival (COPERNICUS) study. Circulation, 106(17), 2194-2199.
  • Tendera, M., Coats, A., Fowler, M., Katus, H., Mohacsi, P., Rouleau, J., Krum, H., Amann-Zalan, I., Shusterman, N., Roecker, E. (2002). Effect of gender on the outcome of patients with severe heart failure treated with carvedilol: Results of the COPERNICUS study. Journal of the American College of Cardiology, 39(Supplement 1), 185A-185A.
  • Bolger, A., Sharma, R., von Haehling, S., Doehner, W., Oliver, B., Rauchhaus, M., Coats, A., Adcock, I., Anker, S. (2002). Effect of interleukin-10 on the production of tumor necrosis factor-alpha by peripheral blood mononuclear cells from patients with chronic heart failure. The American Journal of Cardiology, 90(4), 384-389.
  • Doehner, W., Schoene, N., Rauchhaus, M., Leyva-Leon, F., Pavitt, D., Reaveley, D., Schuler, G., Coats, A., Anker, S., Hambrecht, R. (2002). Effects of xanthine oxidase inhibition with allopurinol on endothelial function and peripheral blood flow in hyperuricemic patients with chronic heart failure - Results from 2 placebo-controlled studies. Circulation, 105(22), 2619-2624.
  • Rouleau, J., Fowler, M., Krum, H., Katus, H., Coats, A., Tendera, M., Mohacsi, P., Amann-Zalan, I., Holcslaw, T., Roecker, E., et al (2002). Efficacy and safety of carvedilol in patients with severe chronic heart failure and low systolic blood pressure: Results of the COPERNICUS study. Journal of the American College of Cardiology, 39(Supplement 1), 171A-172A.
  • Davos, C., Davlouros, P., Wensel, R., Francis, D., Davies, L., Kilner, P., Coats, A., Piepoli, M., Gatzoulis, M. (2002). Global impairment of cardiac autonomic nervous activity late after repair of tetralogy of Fallot. Circulation, 106(Supplement 1), I-69-I-75.
  • Cowie, M., Fox, K., Wood, D., Metcalfe, C., Thompson, S., Coats, A., Poole-Wilson, P., Sutton, G. (2002). Hospitalization of patients with heart failure - A population-based study. European Heart Journal, 23(11), 877-885.
  • Anker, S., Coats, A. (2002). How to RECOVER from RENAISSANCE? The significance of the results of RECOVER, RENAISSANCE, RENEWAL and ATTACH. International Journal of Cardiology, 86(2-3), 123-130.
  • Kalra, P., Genth-Zotz, S., Coats, A., Anker, S. (2002). Human pituitary growth hormone and cancer risk. The Lancet, 360(9347), 1791-1792.
  • Shamim, W., Yousufuddin, M., Cicoira, M., Gibson, D., Coats, A., Henein, M. (2002). Incremental changes in QRS duration in serial ECGs over time identify high risk elderly patients with heart failure. Heart, 88(1), 47-51.
  • Faris, R., Henein, M., Coats, A. (2002). Influence of gender and alcohol on mortality in nonischemic dilated cardiomyopathy. Journal of the American College of Cardiology, 39(Sup.1), 144-144.
  • Doehner, W., Rauchhaus, M., Godsland, I., Egerer, K., Niebauer, J., Sharma, R., Cicoira, M., Florea, V., Coats, A., Anker, S. (2002). Insulin resistance in moderate chronic heart failure is related to hyperleptinaemia, but not to norepinephrine or TNF-alpha. International Journal of Cardiology, 83(1), 73-81.
  • Yousufuddin, M., Shamim, W., Flather, M., Amrani, M., Coats, A. (2002). Inter-relationship of endothelin-1 and natriuretic peptide secretory responses to acute exercise in patient with chronic heart failure and healthy controls. Journal of the American College of Cardiology, 39(Supplement 1), 147-147.
  • Krum, H., Mohacsi, P., Katus, H., Tendera, M., Rouleau, J., Fowler, M., Coats, A., Roecker, E., Packer, M. (2002). Is additional neurohormonal antagonism useful in patients with severe chronic heart failure already receiving a combination of neurohormonal antagonists? Results of the COPERNICUS study. Journal of the American College of Cardiology, 39(Supplement 1), 177A-178A.
  • Yousufuddin, M., Amrani, M., Shamim, W., Al-Nasser, F., Amin, F., Banner, N., Coats, A. (2002). L-arginine for partial resynchronization of abnormal peripheral vascular reactivity in heart failure: A prospective randomized double-blind study. Journal of the American College of Cardiology, 39(Supplement 2), 452A-452A.
  • Cicoira, M., Davos, C., Doehner, W., Franceschini, L., Zanolla, L., Coats, A., Zardini, P., Anker, S. (2002). Lean tissue-adjusted versus body weight-adjusted peak oxygen consumption and mortality prediction in chronic heart failure. Journal of the American College of Cardiology, 39(1), 148-148.
  • Coats, A. (2002). MADIT II, the Multi-center Autonomic Defibrillator Implantation Trial II stopped early for mortality reduction, has ICD therapy earned its evidence-based credentials? International Journal of Cardiology, 82(1), 1-5.
  • Bolger, A., Sharma, R., Li, W., Leenarts, M., Kalra, P., Kemp, M., Coats, A., Anker, S., Gatzoulis, M. (2002). Neurohormonal activation and the chronic heart failure syndrome in adults with congenital heart disease. Circulation, 106(1), 92-99.
  • Coats, A. (2002). Omapatrilat - the story of Overture and Octave. International Journal of Cardiology, 86(1), 1-4.
  • Coats, A. (2002). Origin of symptoms in patients with cachexia with special reference to weakness and shortness of breath. International Journal of Cardiology, 85(1), 133-139.
  • Corra, U., Giordano, A., Bosimini, E., Mezzani, A., Piepoli, M., Coats, A., Giannuzzi, P. (2002). Oscillatory ventilation during exercise in patients with chronic heart failure - Clinical correlates and prognostic implications. Chest, 121(5), 1572-1580.
  • Genth-Zotz, S., von Haehling, S., Bolger, A., Kalra, P., Wensel, R., Coats, A., Anker, S. (2002). Pathophysiologic quantities of endotoxin-induced tumor necrosis factor-alpha release in whole blood from patients with chronic heart failure. The American Journal of Cardiology, 90(11), 1226-1230.
  • Adamopoulos, S., Parissis, J., Karatzas, D., Kroupis, C., Georgiadis, M., Karavolias, G., Paraskevaidis, J., Koniavitou, K., Coats, A., Kremastinos, D. (2002). Physical training modulates proinflammatory cytokines and the soluble Fas/soluble Fas ligand system in patients with chronic heart failure. Journal of the American College of Cardiology, 39(4), 653-663.
  • Hartmann, F., Richardt, G., Packer, M., Coats, A., Fowler, M., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Castaigne, A., et al (2002). Plasma N-terminal pro-BNP predicts the occurrence of major clinical events in severe chronic heart failure: Results of a substudy of the COPERNICUS trial. Journal of the American College of Cardiology, 39(Supplement 1), 200A-200A.
  • Coats, A. (2002). Positive inotropy for acute heart failure complicating myocardial infarction. European Heart Journal, 23(18), 1405-1406.
  • Cleland, J., Penneli, D., Webster, J., Ray, S., Bhattacharya, A., Coats, A., Lahiri, A., Macfarlane, P., Mule, J., Vered, Z., et al (2002). Prevalence of hibernating myocardium and reversible silent myocardial ischemia in patients with heart failure due to coronary artery disease: Baseline data from the CHRISTMAS study. Journal of the American College of Cardiology, 39(Suppl 1), 187A-187A.
  • Wilson, K., Francis, D., Wensel, R., Coats, A., Parker, K. (2002). Relationship between detrended fluctuation analysis and spectral analysis of heart-rate variability. Physiological Measurement, 23(2), 385-401.
  • Scott, A., Davies, L., Coats, A., Piepoli, M. (2002). Relationship of skeletal muscle metaboreceptors in the upper and lower limbs with the respiratory control in patients with heart failure. Clinical Science, 102(1), 23-30.
  • Shamim, W., Yousufuddin, M., Xiao, H., Flather, M., Henein, M., Gibson, D., Coats, A. (2002). Septal q waves as an indicator of risk of mortality in elderly patients with chronic heart failure. American Heart Journal, 144(4), 740-744.
  • Shibata, M., Flather, M., Bohm, M., Borbola, J., Cohen-Solal, A., Dumitrascu, D., Ferrari, R., Lechat, P., Parkhomenko, A., Coats, A., et al (2002). Study of the Effects of Nebivolol Intervention on Outcomes and Rehospitalisation in Seniors with Heart Failure (SENIORS). Rationale and design. International Journal of Cardiology, 86(1), 77-85.
  • Florea, V., Henein, M., Rauchhaus, M., Koloczek, V., Sharma, R., Doehner, W., Poole-Wilson, P., Coats, A., Anker, S. (2002). The cardiac component of cardiac cachexia. American Heart Journal, 144(1), 45-50.
  • Cleland, J., Pennell, D., Ray, S., Coats, A., Lahri, A., Macfarlane, P., Mule, J., Vered, Z., Murray, G. (2002). The Carvedilol Hibernation Reversible Ischemia Trial: Marker of success (CHRISTMAS). Journal of the American College of Cardiology, 39(Supplement 1), 172A-172A.
  • Rauchhaus, M., Gross, M., Schultz, S., Francis, D., Greiser, P., Norwig, A., Weidhase, L., Coats, A., Dietz, R., Anker, S., et al (2002). The E-selectin SER128ARG gene polymorphism and restenosis after successful coronary angioplasty. International Journal of Cardiology, 83(3), 249-257.
  • Coats, A. (2002). The metabolic extension of research in cardiology into the better understanding of cachexia: role of the International Journal of Cardiologyi - Preface. International Journal of Cardiology, 85(1), 1-3.
  • Kalra, P., Anagnostopoulos, C., Bolger, A., Coats, A., Anker, S. (2002). The regulation and measurement of plasma volume in heart failure. Journal of the American College of Cardiology, 39(12), 1901-1908.
  • Coats, A. (2002). Treatment of heart failure. Hospital Medicine: for primary care physicians, 63(8), 497-497.
  • Coats, A. (2002). What do Cochrane reviews tell us about anti-thrombotic therapy in heart failure with sinus rhythm? QJM, 95(7), 419-421.

2001

  • Scott, A., Francis, D., Davies, L., Coats, A., Piepoli, M. (2001). A novel treadmill exercise test protocol with improved metabolic plateau formation. European Heart Journal, , 195-195.
  • Yousufuddin, M., Flather, M., Shamim, W., Yousef, Z., Marber, M., Amrani, M., Banner, N., Kemp, M., Hooper, J., Coats, A. (2001). A short course of l-arginine improves exercise capacity and endothelial function in chronic heart failure: A prospective, randomised, double blind trial. Journal of the American College of Cardiology, , 211A-211A.
  • Coats, A. (2001). A sympathetic heart and the art of dying. European Heart Journal, 22, 1069-1071.
  • Anker, S., Volterrani, M., Pflaum, C., Strasburger, C., Osterziel, K., Doehner, W., Ranke, M., Poole-Wilson, P., Giustina, A., Dietz, R., Coats, A. (2001). Acquired growth hormone resistance in patients with chronic heart failure: Implications for therapy with growth hormone. Journal of the American College of Cardiology, 38, 443-452.
  • Coats, A. (2001). Angiotensin Receptor Blockers - finally the evidence is coming in: IDNT and RENAAL. International Journal of Cardiology, 79, 99-102.
  • Parissis, J., Adamopoulos, S., Karatzas, D., Kroupis, C., Georgiadis, M., Karavolias, G., Koniavitou, K., Karas, S., Coats, A. (2001). Anti-inflammatory effects of physical training are associated with improvement in endothelial function of chronic heart failure patients. European Heart Journal, , 684-684.
  • Bolger, A., Rashid, M., Rauchhaus, M., Sharma, R., Doehner, W., Stephens,, R., Kemp, M., Barclay, G., Coats, A., Anker, S. (2001). Antiendotoxin core antibody levels and endotoxin exposure in non-oedematous severe chronic heart failure. European Heart Journal, , 48-48.
  • Schmidt, H., Rauchhaus, M., Francis, D., Davis, C., Nuding, S., Peschel, T., Schmidt, D., Coats, A., Opitz, H., Werdan, K. (2001). Assessment of chemoreflex sensitivity in free breathing young subjects by correction for respiratory influence. European Heart Journal, 78, 157-165.
  • Yousufuddin, M., Henein, M., Flather, M., Shamim, W., Al-Nasser, F., Kemp, M., Hooper, J., Banner, N., Amrani, M., Coats, A. (2001). Atrial natriuretic peptide compensates for the attenuated brain natriuretic peptide response to increased endothelin-1 production in patients with chronic heart failure. European Heart Journal, , 502-502.
  • Doehner, W., Rauchhaus, M., Egerer, K., Banasiak, W., Coats, A., Anker, S., Piepoli, M., Ponikowski, P. (2001). Augmented peripheral chemosensitivity and periodic breathing pattern are related to elevated levels of the ob gen product leptin in patients with chronic heart failure. Journal of the American College of Cardiology, , 191A-191A.
  • Doehner, W., Piepoli, M., Coats, A., Anker, S., Ponikowski, P., Egerer, K. (2001). Augmented peripheral chemosensitivity and periodic breathing pattern in patients with chronic heart failure are related to elevated levels of the Ob gene product leptin. European Heart Journal, , 294-294.
  • Anker, S., Davos, C., Francis, D., Segal, R., Santoro, E., Poole-Wilson, P., Pitt, B., Coats, A. (2001). Body mass index, obesity, and cachexia vs survival in chronic heart failure: Results from the ELITE 2 study. Journal of the American College of Cardiology, , 203A-203A.
  • Coats, A. (2001). CAPRICORN: a story of alpha allocation and beta-blockers in left ventricular dysfunction post-MI. International Journal of Cardiology, 78, 109-113.
  • Scott, A., Francis, D., Davies, L., Kemp, M., Hooper, J., Coats, A., Piepoli, M. (2001). Chemical mediators of exaggerated muscle ergoreflex activity in chronic heart failure: role of prostaglandins and hydrogen ions in reflex ventilatory control. European Heart Journal, , 297-297.
  • Cicoira, M., Davos, C., Florea, V., Shamim, W., Doehner, W., Coats, A., Anker, S. (2001). Chronic heart failure in the very elderly: Clinical status, survival, and prognostic factors in 188 patients more than 70 years old. American Heart Journal, 142, 174-180.
  • Fox, K., Cowie, M., Wood, D., Coats, A., Gibbs, J., Underwood, S., Turner, R., Poole-Wilson, P., Davies, S., Sutton, G. (2001). Coronary artery disease as the cause of incident heart failure in the population. European Heart Journal, 22, 228-236.
  • Faris, R., Coats, A., Purcell, H., Henein, M. (2001). Depression is common and significantly associated with reduced survival in patients with dilated cardiomyopathy. European Heart Journal, , 414-414.
  • Francis, D., Davies, L., Coats, A. (2001). Diagnostic exercise physiology in chronic heart failure. Heart, 86, 17-20.
  • Al-Nasser, F., Doehner, W., Kaczmarek, A., Ponikowski, P., Piepoli, M., Coats, A., Henein, M. (2001). Echocardiographic derived variables predict intolerability to carvedilol in chronic heart failure. Journal of the American College of Cardiology, , 445A-445A.
  • Davies, L., Francis, D., Scott, A., Ponikowski, P., Piepoli, M., Coats, A. (2001). Effect of altering conditions of the sequence method on baroreflex sensitivity. Journal of Hypertension, 19, 1279-1287.
  • Tendera, M., Mohacsi, P., Krum, H., Fowler, M., Coats, A., Rouleau, J., Castaigne, A., Amann-Zalan, I., Staiger, C., Holcslaw, T., et al (2001). Effect of carvdilol on patients' well-being in severe chronic heart failure: Results of the COPERNICUS study. Circulation, , 719-719.
  • Carson, P., Fowler, M., Mohacsi, P., Krum, H., Tendera, M., Coats, A., Rouleau, J., Holcslaw, T., Staiger, C., Roecker, E., et al (2001). Effect of carvedilol in black patients with severe chronic heart failure: Results of the COPERNICUS study. Circulation, , 754-754.
  • Fowler, M., O'Connor, C., Carson, P., Tendera, M., Katus, H., Krum, H., Mohacsi, P., Coats, A., Rouleau, J., Roecker, E., et al (2001). Effect of carvedilol on frequency and severity of hospitalization in severe chronic heart failure: Results of the COPERNICUS study. Circulation, , 753-754.
  • Amann-Zalan, I., Tendera, M., Packer, M., Fowler, M., Katus, H., Krum, H., Mohacsi, P., Rouleau, J., Castaigne, A., Coats, A. (2001). Effect of carvedilol on global assessment of patients with severe chronic heart failure: the COPERNICUS study. European Heart Journal, , 299-299.
  • Amann-Zalan, I., Coats, A., Fowler, M., Katus, H., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Packer, M., Carson, P. (2001). Effect of carvedilol on hospitalization in patients with severe chronic heart failure: results of the COPERNICUS study. European Heart Journal, , 300-300.
  • Packer, M., Coats, A., Fowler, M., Katus, H., Krum, H., Mohacsi, P., Rouleau, J., Tendera, M., Castaigne, A., Roecker, E., et al (2001). Effect of carvedilol on survival in severe chronic heart failure. New England Journal of Medicine, 344, 1651-1658.
  • Doehner, W., Rauchhaus, M., Leyva, F., Coats, A., Anker, S. (2001). Effect of xanthine oxidase inhibition with allopurinol on peripheral blood flow in CHF patients in a randomised, placebo-controlled, double-blind, cross-over study. European Heart Journal, , 403-403.
  • Al-Nasser, F., Bukachi, F., Yousufuddin, M., Henein, M., Ponikowski, P., Coats, A., Anker, S. (2001). Effects of carvedilol on left ventricular function: an echocardiographic follow-up study. European Heart Journal, , 298-298.
  • Yousufuddin, M., Flather, M., Wang, D., Yousef, Z., Marber, M., Parker, K., Wilson, K., Banner, N., Amrani, M., Coats, A. (2001). Effects of oral L-arginine supplement on peripheral vascular function in chronic heart failure a prospective, randomised, double-blind, placebo-controlled study. European Heart Journal, , 47-47.
  • Rauchhaus, M., Doehner, W., Bolger, A., Sharma, R., Schmidt, H., Davos, C., Kemp, M., Coats, A., Anker, S. (2001). Endotoxin and severity of chronic heart failure. Journal of the American College of Cardiology, , 190A-190A.
  • Ponikowski, P., Francis, D., Piepoli, M., Davies, L., Chua, T., Davos, C., Florea, V., Banasiak, W., Poole-Wilson, P., Coats, A., Anker, S. (2001). Enhanced ventilatory response to exercise in patients with chronic heart failure and preserved exercise tolerance - Marker of abnormal cardiorespiratory reflex control and predictor of poor prognosis. Circulation, 103, 967-972.
  • Piepoli, M., Wensel, R., Ponikowski, P., Francis, D., Davies, L., Capucci, A., Coats, A. (2001). Ergoreflex overactivation predicts reduced baroreflex sensitivity and autonomic abnormalities in chronic heart failure patients. European Heart Journal, , 548-548.
  • Bolger, A., Rashid, M., Sharma, R., Rauchhaus, M., Doehner, W., Stephens,, R., Barclay, R., Coats, A., Anker, S. (2001). Evidence of endotoxin exposure in patients with severe chronic heart failure by determination of antiendotoxin core antibody levels. Journal of the American College of Cardiology, , 190A-190A.
  • Coats, A. (2001). Exciting new drugs on the horizon - Eplerenone, a selective aldosterone receptor antagonist (SARA). International Journal of Cardiology, 80, 1-4.
  • Cicoira, M., Zanolla, L., Rossi, A., Golia, G., Franceschini, L., Cabrini, G., Bonizzato, A., Graziani, M., Anker, S., Coats, A., et al (2001). Failure of aldosterone suppression despite angiotensin-converting enzyme (ACE) inhibitor administration in chronic heart failure is associated with ACE DD genotype. Journal of the American College of Cardiology, 37, 1808-1812.
  • Cicoira, M., Bolger, A., Doehner, W., Rauchhaus, M., Davos, C., Sharma, R., Al-Nasser, F., Coats, A., Anker, S. (2001). High tumor necrosis factor levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. Journal of the American College of Cardiology, , 190A-190A.
  • Cicoira, M., Bolger, A., Doehner, W., Rauchhaus, M., Davos, C., Sharma, R., Al-Nasser, F., Coats, A., Anker, S. (2001). High tumour necrosis factor-alpha levels are associated with exercise intolerance and neurohormonal activation in chronic heart failure patients. Cytokine, 15, 80-86.
  • Doehner, W., Rauchhaus, M., Egerer, K., Strasburger, C., Pflaum, C., Davos, C., Coats, A., Anker, S. (2001). Hyperleptinaemia in chronic heart failure relates to growth hormone binding protein in male patients with and without cardiac cachexia. European Heart Journal, , 306-306.
  • Doehner, W., Rauchhaus, M., Egerer, K., Pflaum, C., Strasburger, C., Davos, C., Coats, A., Anker, S. (2001). Hyperleptinemia in chronic heart failure relates to growth hormone binding protein in male patients with and without cardiac cachexia. Journal of the American College of Cardiology, , 245A-245A.
  • Parissis, J., Adamopoulos, S., Karatzas, D., Kroupis, C., Karavolias, G., Paraskevaidis, J., Koniavitou, K., Karas, S., Kremastinos, D., Coats, A. (2001). Immunomodulatory effects of physical training in chronic heart failure. European Heart Journal, , 197-197.
  • Yousufuddin, M., Henein, M., Flather, M., Wang, D., Shamim, W., O'Sullivan, C., Kemp, M., Kazzam, E., Banner, N., Amrani, M., Coats, A. (2001). Incremental importance of peak-exercise plasma levels of endothelin-I and natriuretic peptides in chronic heart failure. Journal of Cardiovascular Pharmacology, 38, 468-473.
  • Hughes, P., Hart, N., Hamnegard, C., Green, M., Coats, A., Moxham, J., Polkey, M. (2001). Inspiratory muscle relaxation rate slows during exhaustive treadmill walking in patients with chronic heart failure. American Journal of Respiratory and Critical Care Medicine, 163, 1400-1403.
  • Doehner, W., Pflaum, C., Rauchhaus, M., Godsland, I., Egerer, K., Cicoira, M., Florea, V., Sharma, R., Bolger, A., Coats, A., Anker, S., et al (2001). Leptin, insulin sensitivity and growth hormone binding protein in chronic heart failure with and without cardiac cachexia. European Journal of Endocrinology, 145, 727-735.
  • Coats, A. (2001). Life, quality of life and choice in an ageing society. International Journal of Cardiology, 78, 1-3.
  • Scott, A., Ponikowski, P., Anker, S., Davos, C., Rauchhaus, M., Coats, A., Piepoli, M., Capucci, A. (2001). Limb lean tissue relates to exercise intolerance and muscle reflexes in chronic heart failure patients. European Heart Journal, , 405-405.
  • Coats, A. (2001). Making choices in cardiology: difficulties of rationing and equality of access. International Journal of Cardiology, 78, 209-212.
  • Coats, A. (2001). Medical malpractice, murder and the academic community: trouble ahead. International Journal of Cardiology, 79, 1-4.
  • Ponikowski, P., Chua, T., Francis, D., Capucci, A., Coats, A., Piepoli, M. (2001). Muscle Ergoreceptor Overactivity Reflects Deterioration in Clinical Status and Cardiorespiratory Reflex Control in Chronic Heart Failure. Circulation, 104, 2324-2330.
  • Scott, A., Capucci, A., Piepoli, M., Ponikowski, P., Anker, S., Davos, C., Rauchhaus, M., Coats, A. (2001). Muscle lean tissue reflects deterioration in clinical status and cardiorespiratory reflex control in chronic heart failure. European Heart Journal, , 406-406.
  • Coats, A. (2001). Pericardial fluid - dispensable or indispensable fluid and an example of patentable bio-diversity. International Journal of Cardiology, 77, 109-111.
  • Ponikowski, P., Chua, T., Anker, S., Francis, D., Doehner, W., Banasiak, W., Poole-Wilson, P., Piepoli, M., Coats, A. (2001). Peripheral chemoreceptor hypersensitivity - An ominous sign in patients with chronic heart failure. Circulation, 104, 544-549.
  • Adamopoulos, S., Parissis, J., Kroupis, C., Georgiadis, M., Karatzas, D., Karavolias, G., Koniavitou, K., Coats, A., Kremastinos, D. (2001). Physical training reduces peripheral markers of inflammation in patients with chronic heart failure. European Heart Journal, 22, 791-797.
  • Harrington, D., Anker, S., Coats, A. (2001). Preservation of exercise capacity and lack of peripheral changes in asymptomatic patients with severely impaired left ventricular function. European Heart Journal, 22, 392-399.
  • Coats, A., Anker, S., Roecker, E., Schultz, M., Staiger, C., Amann-Zalan, I., Shusterman, N., Packer, M. (2001). Prevention and reversal of cardiac cachexia in patients with severe heart failure by carvedilol: Results of the COPERNICUS study. Circulation, , 437-437.
  • Shamim, W., Yousufuddin, M., Francis, D., Gualdiero, P., Honour, J., Anker, S., Coats, A. (2001). Raised urinary glucocorticoid and adrenal androgen precursors in the urine of young hypertensive patients: possible evidence for partial glucocorticoid resistance. Heart, 86, 139-144.
  • Davies, L., Francis, D., Ponikowski, P., Piepoli, M., Coats, A. (2001). Relation of heart rate and blood pressure turbulence following premature ventricular complexes to baroreflex sensitivity in chronic congestive heart failure. The American Journal of Cardiology, 87, 737-742.
  • Scott, A., Davies, L., Francis, D., Coats, A., Piepoli, M. (2001). Role of skeletal muscle afferents in the respiratory control in chronic heart failure. European Heart Journal, , 405-405.
  • Krum, H., Coats, A., Fowler, M., Mohacsi, P., Rouleau, J., Tendera, M., Roecker, E., Amann-Zalan, I., Staiger, C., Holcslaw, T., et al (2001). Safety and tolerability of carvedilol in patients with severe chronic heart failure: Results of the COPERNICUS study. Circulation, , 717-717.
  • Rauchhaus, M., Doehner, W., Davos, C., Sharma, R., Bolger, A., Gabriel, H., Kemp, M., Coats, A., Anker, S. (2001). Serum total cholesterol, high-density lipoprotein, and prognosis in patients with chronic heart failure. Journal of the American College of Cardiology, , 156A-156A.
  • Mohacsi, P., Fowler, M., Krum, H., Tendera, M., Coats, A., Rouleau, J., Amann-Zalan, I., Holcslaw, T., Roecker, E., Packer, M. (2001). Should physicians avoid the use of beta-blockers in patients with heart failure who have diabetes? Results of the COPERNICUS study. Circulation, , 754-754.
  • Davos, C., Francis, D., Segal, R., Poole-Wilson, P., Pitt, P., Coats, A., Anker, S. (2001). Survival in chronic heart failure in the ELITE-2 study: the importance of body weight, weight loss and uric acid. European Heart Journal, , 265.
  • Coats, A. (2001). The effects of angiotensin receptor antagonists on mortality and morbidity in heart failure - and an interaction with beta blockade. International Journal of Cardiology, 77, 1-4.
  • Scott, A., Davies, L., Capucci, A., Coats, A., Piepoli, M. (2001). The relationship between skeletal muscle metaboreceptors in the upper and lower limbs and the respiratory control in heart failure. European Heart Journal, , 297-297.
  • Kalra, P., Anker, S., Struthers, A., Coats, A. (2001). The role of C-type natriuretic peptide in cardiovascular medicine. European Heart Journal, 22, 997-1007.
  • Henein, M., O'Sullivan, C., Coats, A., Gibson, D., Sheppard, M. (2001). TOE with 3D reconstruction reveals organic tricuspid valve disease in patients with severe valve regurgitation and apparently normal cusp morphology. Journal of Pathology, , 41A-41A.
  • Doehner, W., Rauchhaus, M., Florea, V., Sharma, R., Bolger, A., Davos, C., Coats, A., Anker, S. (2001). Uric acid in cachectic and noncachectic patients with chronic heart failure: Relationship to leg vascular resistance. American Heart Journal, 141, 792-799.
  • Scott, A., Francis, D., Davies, L., Coats, A., Piepoli, M. (2001). Validation of a treadmill exercise test protocol with improved metabolic plateau formation in patients with chronic congestive heart failure. The American Journal of Cardiology, 87, 1328-1331.
  • Sharma, R., Florea, V., Bolger, A., Doehner, W., Florea, N., Coats, A., Hodson, M., Anker, S., Henein, M. (2001). Wasting as an independent predictor of mortality in patients with cystic fibrosis. Thorax, 56, 746-750.
  • Florea, V., Moon, J., Pennell, D., Doehner, W., Coats, A., Anker, S. (2001). Wasting of the left ventricle in patients with cardiac cachexia: A prospective cardiovascular magnetic resonance study. Circulation, , 168-168.
  • Kalra, P., Anker, S., Coats, A. (2001). Water and sodium regulation in chronic heart failure: the role of natriuretic peptides and vasopressin. Cardiovascular Research, 51, 495-509.
  • Coats, A. (2001). What causes the symptoms of heart failure? Heart, 86, 574-578.
  • Doehner, W., Coats, A., Anker, S. (2001). Xanthine oxidase inhibition with allopurinol improves peripheral blood flow in hyperuricaemic CHF patients in a placebo controlled, double blind, cross-over treatment study. Circulation, , 437-437.

To update your profile click here. For support on your academic profile contact .